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PENILAIAN EKSTRAK METANOL KASAR Fruktus Viticis SEBAGAI ANTI-
OKSIDAN DAN ANTI-RADANG DALAM TAPAK TANGAN EDEMA AKUT 




Keradangan merupakan mekanisma perlindungan semulajadi bagi melindungi badan 
daripada pelbagai kecederaan atau jangkitan dan akan menyebabkan rasa sakit. 
Tujuan kajian ini adalah untuk menilai kesan ekstrak buah tumbuhan pantai Vitex 
rotundifolia iaitu Fructus viticis sebagai agen anti-oksida dan anti-keradangan ke atas 
proses keradangan akut dalam edema tapak kaki oleh karagenan. Fructus viticis ialah 
buah kepada Vitex rotundifolia, dan telah digunakan secara tradisional bagi merawat 
keradangan. Sebanyak 30 ekor tikus Sprague-Dawley jantan (8-12 minggu dengan 
berat badan 220-280 g) telah digunakan dalam kajian ini. Semua tikus telah 
dibahagikan kepada kumpulan rawatan yang berbeza dimana setiap kumpulan 
mengandungi 6 ekor tikus iaitu Kumpulan: A (Vehicle-DMSO + Saline); B (Vehicle-
DMSO + 2% λ-Carrageenan); C (Extract + Saline); D (Extract + 2% λ-Carrageenan); 
E (LNMMA + 2% λ-Carrageenan). Vehicle (DMSO) dan ekstrak disuntik dengan 
suntikan subplantar 30 minit sebelum induksi keradangan dan kesakitan akut 
menggunakan 100 uL 2% λ-carrageenan atau saline ke kaki kanan belakang tikus. 
Edema kaki diukur dengan menggunakan vernier caliper digital, tingkah laku sakit 
ditaksir menggunakan ujian Randall-Selitto dan tekanan darah sistolik diambil 
menggunakan kaedah “tail-cuff” pada selang waktu yang berlainan (0.5, 2, 4. 6, 8, 12 
dan 24 jam). Pada akhir kajian, semua haiwan telah dikorbankan dan sampel darah 
dikumpulkan melalui tusukan jantung untuk analisis darah penuh. Ekstrak metanol 
xvii 
 
‘Fructus viticis’ menunjukkan kesan anti-keradangan dengan mengurangkan 
pembentukan edema kaki pada 4 hingga 6 jam dan seterusnya menghasilkan kesan 
analgesik pada sela masa tertentu. Tambahan pula, keupayaan Fructus viticis 
mengurangkan keradangan dan juga kesakitan boleh dikaitkan dengan keupayaan 
ekstrak mengurangkan kemasukan sel imun terutamanya monosit/makrofaj ke dalam 
tapak kaki belakang tikus. Selain itu, kesan anti-keradangan dan analgesik oleh 
ekstrak Fructus viticis mungkin adalah kesan secara langsung aktiviti antioksida oleh 
Fructus viticis. Kesimpulannya, buah V. rotundifolia berpotensi untuk berkembang 
menjadi ubat anti-keradangan dan analgesic yang baik di bidang farmaseutikal pada 
masa hadapan.   
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EVALUATION OF Fructus Viticis METHANOLIC CRUDE EXTRACT AS 
ANTI-OXIDANT AND ANTI-INFLAMMATORY IN CARRAGEENAN 




Inflammation is a natural defense mechanism against various harmful stimuli that 
results in pain sensation. The aim of this study was to evaluate the fruits of Vitex 
rotundifolia known as Fructus Viticis methanolic crude extract as antioxidant and 
anti-inflammatory agents  in carrageenan-induced acute paw oedema. Fructus viticis 
has been used as a traditional medicine for the treatment of inflammation. This acute 
(24 hour) inflammation study involved 30 male Sprague Dawley rats (8-12 weeks 
and 220-280 g). Rats were equally divided into 5 groups: A (Vehicle-DMSO + 
Saline); B (Vehicle-DMSO + 2% λ-Carrageenan); C (Extract + Saline); D (Extract + 
2% λ-Carrageenan); E (LNMMA + 2% λ-Carrageenan). Vehicle (DMSO) and 
extract were injected by sub plantar injection 30 minutes prior to induction of 
inflammatory and acute pain using 100uL of 2 % λ-carrageenan or saline into the 
right hind paw. The paw oedema was determined by using a digital vernier caliper, 
pain behaviour was assessed using Randall-Selitto test and the systolic blood 
pressure was taken using the tail cuff method at different time intervals (0.5, 2, 4. 6, 
8, 12 and 24 hours). At the end of study, all animals were euthanized and blood 
sample were collected via direct cardiac puncture for full blood count analyses.. 
Methanolic extract of the Fructus viticis exhibits anti-inflammatory effects by 
delaying the development of carrageenan-induced paw oedema at 4 h to 6 h which 
subsequently produces analgesic effect at certain period. Moreover, the ability of 
Fructus viticis extract to reduce the paw oedema as well as pain is suggested to be 
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associated with the potential of the extract reduce the infiltration of inflammatory 
cells which specifically the monocytes/macrophages into the hind paw. Furthermore, 
anti-inflammatory and analgesic effects of Fructus viticis extract might be the direct 
consequences of antioxidant activity of Fructus viticis. Overall, the fruit of 
V.rotundifolia have a potential to be developed into a novel anti-inflammatory and 








1.1 Background of Study 
Inflammation is a natural occurrence as body encounters various harmful stimuli 
including pathogens, damaged cells, toxic compounds, irradiation microbial and viral 
infections, exposure to allergens, autoimmune and chronic diseases, obesity, 
consumption of alcohol, tobacco use, and a high-calorie diet (Medzhitov, 2008; 
Takeuchi and Akira, 2010; Freire and Van Dyke, 2013; Chen et al., 2018). It is a 
natural defense mechanism against these harmful stimuli thus it is vital for health as 
it is involved in removing of the harmful materials thus initiating the healing process 
(Hussain et al., 2016). 
Generally, there are five (5) cardinal signs to characterize inflammation which 
are pain (dolor), redness (rubor), warmth (calor), swelling (tumor), and loss of 
function (functio laesa) that results from local immune, vascular and inflammatory 
cell responses to infection or injury (Brune and Hinz, (2004); Libby (2007); 
Takeuchi and Akira (2010). Various mechanisms involves in initiating inflammatory 
response depends on its triggering factors. There are numerous signalling pathways 
that triggered inflammation, including toll-like receptor (TLR) signalling, NF-κB 
pathway and JAK-STAT pathway. Although different factors initiate different 
pathways, there are common mechanisms involved. Cell surface pattern receptors 
recognise harmful stimuli then followed by activation of inflammatory pathways 
which subsequently up-regulates the inflammatory markers and the recruitment of 
inflammatory cells (Libby 2007; Chen et al., 2018). 
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Inflammatory response initiates when host tissues is triggered by harmful 
materials thus results in vascular dilation, enhanced permeability of capillaries, 
increase blood flow and leukocyte recruitment to the infected site (Freire and Van 
Dyke 2013). The first leucocyte recruited to the site of infection is 
polymorphonuclear neutrophils that involve in phagocytotic and microbicidal action. 
Then, second line defence mechanism is initiated by infiltration of mononuclear 
cells, monocytes and macrophages into the inflammation site that will clear cellular 
debris and neutrophils through phagocytosis (Freire and Van Dyke 2013).  
Macrophage activity triggers the releasing of pro-inflammatory cytokines such as 
IL-1β, IL-6, IL-8, IL-12, TNF-α, GM-CSF and anti-inflammatory cytokines such as 
TGF-β (Chen et al., 2018). Additionally, activated macrophage also produced high 
concentration of nitric oxide and reactive oxygen species that can damage cell 
structures such as carbohydrates, nucleic acids, lipids, and proteins and alter their 
functions (Birben et al., 2012; Yanagisawa et al., 2008). Although inflammation is 
necessary for removing noxious stimuli, non-resolving inflammation can cause in 
pathological lesion. Failure to return damaged tissue to homeostasis and delaying of 
apoptosis can results in chronic inflammation including arthritis, asthma, cancers, 
cardiovascular diseases and periodontal diseases (Freire and Van Dyke, 2013). 
Pain is one of the cardinal sign of inflammation due the releasing of molecular 
mediators that sensitise nociceptor neurons (Pinho-ribeiro et al., (2017), Tissue 
injury during inflammation causes more pain sensation thus resulting in 
hypersensitivity or ‘hyperalgesia’. Moreover, common drugs that used to treat 
inflammation and pain such as non-steroidal anti-inflammatory drugs (NSAIDs) are 
known to produce side effect with chronic disorder (Ong et al., 2007). Although it is 
highly effective and most common drug prescribed, some patients may experience 
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severe side effects as NSAIDs are known for multiple adverse effects, including 
gastrointestinal bleeding, cardiovascular side effects, and NSAID induced 
nephrotoxicity (Brune 2007; Wongrakpanich et al., 2018). Realizing the side effects 
of NSAIDs in treating inflammation and diseases, many researchers nowadays are 
looking for more safer treatment with less side effect such us utilizing and 
developing drugs from natural resources such as medicinal plants and herbs (Ausman 
et al., 2010). 
In inflammatory response, leukocytes and mast cells activity enhance the 
production and release of reactive oxygen species (ROS) at the damaged area. ROS 
is a free radical molecule that is highly reactive and unstable as it carries one or more 
unpaired electrons (Arulselvan et al., 2016). ROS become stable by attacking the 
closest stable molecule and taking its electron meanwhile the attacked molecule can 
become a free radical by losing its electron and start a chain reaction cascade causing 
damage to the living cell (Arulselvan et al., 2016). Under physiological conditions, a 
dynamic equilibrium exists between the production of reactive oxygen species (ROS) 
and endogenous antioxidant defense as ROS are neutralized by antioxidant defense 
mechanisms (Suriyaprom et al., 2019). Oxidative stress occurs when ROS levels 
exceed levels of antioxidants as ROS can induce severe oxidative damage to 
macromolecules that leads to cellular dysfunction (Papada and Kaliora; 2019). 
Vitex rotundifolia belong to the plant family Verbenaceae (Lee et al., 2013). Its 
dried ripened fruit has been used as a traditional medicine and is widely used in 
Korea, China, Japan, Pacific Island and Australia for the treatment of asthma, night 
blindness inflammation, headache, migraine, chronic bronchitis, eye pain, and 
gastrointestinal infections (Lee et al., 2013; Rani and Sharma, 2013; Chaudhry et al., 
2019). Moreover, this plant also known as ‘Beach Vitex’ is widely distributed in 
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sandy shores area and can be found throughout sandy beaches of tropics and sub-
tropics. In Southern Thailand and Northeastern of Malaysia, locals prepare 
traditional dessert made from rice flour and it is an important ingredient in ‘nasi 
kerabu’. The leaf extract is added to give color and flavour, the dessert is served with 
grated coconut and granulated sugar.” (Chan et al., 2016).  
Studies have found that V. rotundifolia exhibits various pharmacology activities 
such as anti-inflammatory, cytotoxic, anti-cancer, anti-microbial, anti-nociceptive 
and anti-hyperprolactinemia (Chaudhry et al., 2019; Lee et al., 2013). MeOH extract 
of the fruits of V. rotundifolia, also known as Fructus viticis showed inhibitory 
effects on the nitric oxide (NO) production (Lee et al., 2013). Various phytochemical 
constituent can be isolated from the fruits of V. rotundifolia, Fructus viticis such as 
iridoids, phenylpropanoids, diterpenes, flavonoids, and lignans provide a potential 
explanation for the use of V. rotundifolia as a natural remedy with lesser side effects 
(Lee et al., 2013; Kim and Shim, 2019).    
 
1.2 Problem Statement 
Inflammation is a natural and frequent occurrence when body encounters noxious 
stimuli in order to protect body from harm thus maintain vital health. However, non-
resolving inflammation will results in adverse effects where it can cause pathological 
lesion and tissue injuries.  Failure to return tissue to homeostasis and delaying of 
apoptosis will results in chronic inflammation including arthritis, asthma, cancers, 
cardiovascular diseases and periodontal diseases. Inflammation also associated with 
pain sensation thus resulting in hypersensitivity or ‘hyperalgesia’ which can interfere 
everyday activities. Although NSAIDs are common drug used to reduce 
inflammation and give analgesic effects, patients may experience various side effects 
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of the drugs together with GI complications, including bleeding and perforation. V. 
rotundifolia is widely used in Korea, China, and Japan for the treatment of 
inflammation. However, the usage of V. rotundifolia in treating inflammation is still 
not fully utilised in Malaysia. Studies has found that MeOH extract of V. rotundifolia 
fruits, Fructus Viticis possess various phytochemical constituent such as diterpenes, 
flavonoids, and lignans thus provide a potential explanation for the use of V. 
rotundifolia as a natural remedies for inflammation treatment with lesser side effects 
(Lee et al., 2013; Kim and Shim, 2019).  
 
1.3 Objectives  
1.3.1 General Objectives  
To evaluate Fructus Viticis methanolic crude extract as anti-oxidant and anti-
inflammatory in carrageenan-induced acute paw oedema. 
 
1.3.2 Specific Objectives  
Achievable objectives 
i. To evaluate the anti-inflammatory and analgesic effects of Fructus 
viticis on carrageenan-induced paw oedema. 
ii. To elucidate the effect of Fructus viticis methanolic crude extract on 
infiltration of immune cells via full blood count analysis.  





i. To determine anti-inflammatory effect of Fructus viticis methanolic 
extract on carrageenan-induced nitric oxide production in paw tissues. 
ii. To elucidate the effect of Fructus viticis methanolic crude extract on 
infiltration of immune cells via histopathological analysis.  
 
1.4 Hypothesis 
Fructus viticis methanolic crude extract will have high antioxidant activity. 
Moreover, Fructus viticis methanolic crude extract will reduce paw oedema which 
subsequently inhibit pain. The inhibition of inflammation and pain is associated with 
the ability of the crude extract to inhibit carrageenan-induced NO and infiltration of 
specific inflammatory cells such as neutrophils and monocytes.  
1.5 Rationale of Study  
This study will accentuate natural products which are potent and have lesser 
side effects in preventing inflammatory diseases. This study also could promote a 









Immune system is built with complex innate and adaptive component that are 
capable of responding to changes, thus maintaining tissue homeostasis (Belkaid and 
Hand, 2014). Inflammation is a natural defense mechanism against various harmful 
stimuli, so it is vital for health because it involves removing noxious substances and 
initiating healing processes (Hussain et al., 2016). Immune systems respond to these 
harmful stimuli as it is essential to maintain homeostasis and remove these noxious 
substances (Glass et al., 2010).  
Inflammatory process can be organized into a number of sequential steps (Figure 
2.1) (Shaykhiev et al., 2007). Inflammation occur when triggered by mechanical 
injuries, infections, allergens, toxins, or noxious xenobiotics that disrupt homeostasis 
and need to be sensed to elicit a protective response that aims to ultimately restore 
homeostasis (Chovatiya and Medzhitov, 2014). Tissue damages of infections will 
leads to the release of molecular signals termed damage-associated molecular pattern 
molecules (DAMPs), pathogen-associated molecular pattern molecules (PAMPs, 
released by invading pathogens), or alarmins that will activate tissue resident cells 
thus promotes the release of pro-inflammatory mediators, including pro-
inflammatory cytokines, chemokines, vasoactive amines, and lipid mediators 
(Villeneuve et al., 2018). The releasing of various mediators including cytokines and 
chemokine by tissue cells will contribute to the dynamic process of leukocytes subset 
recruitment (neutrophils, monocytes etc.) to the site of injury by increase local blood 
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flow and vascular permeability (Crasci et al., 2018). Neutrophils are the first 
recruited cells and once in the tissue they initiate inflammation and the clearance of 
pathogens by promoting recruitment of additional granulocytes and monocytes, and 
undergo degranulation responses, oxidative burst and NETosis (an evolutionary 
conserved cell death process distinctly separate to apoptosis and necrosis that trap 
pathogens) (Jones et al., 2016). 
 
 
Figure 2.1 Inflammatory process. Inflammation is initiated by tissue injury, 
caused by physical damage to the tissue barrier or infection. Various mediators 
including chemokine, cytokines and vasoactive amines are released by epithelial 
cells and mast cells (violet) to increase vascular permeability and attract 
inflammatory cells from blood such as neutrophils (blue), monocytes (green) or 
eosinophils (pink), that migrate to the site of injury and kill microbes. Dendritic cells 
(yellow), matured in the presence of pathogens, migrate into regional lymph node, 
where they present antigen to T cells and thereby prime specific immune response 
(Shaykhiev et al., 2007). 
Generally, classical signs of inflammation are redness (rubor), pain (dolor), 
heat (calor), swelling (tumor), and loss of function (functio laesa) (Ji et al., 2016). 
Heat (calor) sensation is caused by the of increased blood flow through dilated 
vessels and release of inflammatory mediators while oedema (tumor) is the result of 
exudation of fluid as well as cells being infiltrated to the site of infection. Moreover, 
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oedema and various mediators from the damaged and inflammatory response caused 
direct effect to the sensory nerves thus result in pain (dolor) sensation. Loss of 
function (functio laesa) can be caused by pain sensation and oedema thus interfere 
the movement of joint as well as replacement of functional cells into the scars tissue 
can result in loss of function (Gurenlian, 2009). 
Inflammation is induced by loss of homeostasis, but also intentionally 
disrupts incompatible homeostatic processes and the resolution phase that restores 
homeostasis after inflammation indicates successful inflammatory response (Kotas 
and Medzhitov, 2015). Resolution of inflammation is important to avoid unnecessary 
tissue damage, reduction of energy, cellular and homoeostatic costs associated with 
inflammation and tissue damage, pain relief, remodelling, regeneration, and 
restoration of function (Gallo et al., 2017). Inflammation resolution involves 
neutrophil apoptosis and their phagocytic removal via efferocytosis, clearance of pro-
inflammatory dead cells and cytokines, and recruitment or phenotype switching of 
macrophages to anti-inflammatory phenotype (Kulkarni et al., 2016). If 
inflammatory processes are not resolved, and active inflammation continues in a 
dysregulated fashion, it will lead to prolonged and chronic inflammation that usually 
associated with various chronic diseases such as arthritis, lupus, and periodontis 
(Zhou et al., 2016).  
2.1.1 Acute Inflammation 
Acute inflammation is a short-term process that require external stimulus as 
they response towards various harmful stimuli, usually occurring within minutes or 
hours and persist for a couple of days or weeks (Fritsch et al., 2019; Abudukelimu et 
al., 2018). It is activated by pathogen-associated molecular patterns (PAMPs) or 
danger-associated molecular patterns (DAMPs) through the Toll-like receptor (TLR) 
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systems and other innate immune receptors that able to recognize various harmful 
stimuli including viruses, bacteria, endogenous or exogenous danger signals, or 
foreign particles (MacLeod and Mansbridge, 2016).  
Acute inflammation is characterized with specific cellular events, including 
increased permeability of the endothelium and epithelium, infiltration of 
polymorphonuclear leukocytes, inflammatory macrophages, and lymphocytes to sites 
of infection or injury, and subsequent tissue oedema (Duvall and Levy, 2016).   The 
activation of transcription factors such as NF-κB and STAT3, inflammatory enzymes 
such as cyclooxygenase-2 (COX-2), matrix metalloproteinase-9 (MMP-9), and 
inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), interleukins 
(IL) such as IL-1, IL-6, IL-8, and chemokines are the main molecular mediators of 
inflammatory response (Kunnumakkara et al., 2018). As inflammation achieves its 
goals and the wound is cleared of contamination, the acute wound healing process 
and inflammatory stage move to a reparative stage (MacLeod and Mansbridge, 
2016).  
2.1.2 Chronic Inflammation 
Although inflammation inhibits infections or harmful materials from 
spreading across infection sites (Nathan and Ding, 2010), inflammation has been 
associated with various diseases such as rheumatoid arthritis, asthma, inflammatory 
bowel disease, neurodegenerative diseases and cancer. These diseases are caused by 
untreated or poor management of acute inflammation that leads to chronic 
inflammation (Hussein et al., 2013).  Prolonged infiltration of various immune cells 
may turn acute inflammation into chronic inflammation, which persists over months 
or years, beyond the presence of the external stimuli (Abudukelimu et al., 2018). 
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 “Chronic inflammation is defined as persistence of inflammatory processes 
beyond their physiological function, resulting in tissue destruction” (Nasef et al., 
2017).  Chronic inflammation are the results of altered mechanisms and the 
magnitude of acute inflammatory responses, potentially exacerbating and prolonging 
tissue inflammation and adversely affecting healing (Mu et al., 2016). Chronic 
inflammation may result in long-term tissue damage that caused by hypoxia, cell 
death, cellular necrosis, or autophagy, arthritis, and other autoimmune disorders, or 
from other non-acute injuries that also result in the recruitment of phagocytic and 
immune cells and in the production of pro-inflammatory cytokines (Ross, 2017). It 
results in increase of toxic products of inflammation, such as reactive oxygen species 
(ROS) and cathepsins released from lysosomes, which rupture in the process of cell 
death (Cox et al., 2020). Chronic inflammation is distinguished by mononuclear cell 
infiltration such as monocyte and lymphocytes, fibroblasts proliferation, collagen 
fibers, and connective tissue formation, which ultimately result in formation of 
granuloma (Abdulkhaleq et al., 2018).  
2.2 Role of immune cell during inflammation 
The inflammatory response can be mediated by two types of immune system 
which are innate and adaptive immunity (Kinsey et al, 2008). Innate immune system 
is the first line host defense that responded to foreign materials before the adaptive 
immune system was able to take over (Whyte, 2007). The innate immune system is 
activated at the early stage of infectious or inflammatory states in a non-antigen-
specific fashion and is comprised of immune cells such as neutrophils, 
monocytes/macrophages, dendritic cells (DCs), natural killer (NK) cells and natural 
killer T (NKT) cells. Meanwhile, the adaptive immune system reacts to specific 
antigens such as pathogens or dead self-cells after several days of infection, 
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including DC maturation and antigen presentation, CD4 and CD8 T lymphocyte 
proliferation and activation, and T to B lymphocyte interactions (Kinsey et al.,, 
2008).   
2.2.1 Neutrophils 
Neutrophils is one of the polymorphonuclear leukocytes (PMNs), a special 
family of white blood cells are the most abundant leukocyte population in the blood, 
comprising 50–60% of the circulating leukocytes (25×109 cells) and one of the 
important components of the innate immune response (Fournier and Parkos, 2012). 
According to Selders et al., (2017), neutrophils are the first immune cells to response 
to injuries or pathogen infection and the presence of neutrophils indicates that these 
cell types play a critical role in the onset of inflammation. When body is injured of 
infected, neutrophils migrates out of the circulatory system through dilated vessels 
and recruited via chemotaxis to the site of infection (Selders et al., 2017).  
Neutrophils are activated after exposure to numerous triggering factors 
including pro-inflammatory cytokines such as interferon (IFN)-γ and 
granulocyte/macrophage-colony stimulating factor (GM-CSF), which induces the 
activation of STAT transcription factor members, whereas tumor necrosis factor 
(TNF-α) and interleukin (IL-1β) induces the NF-κB classical inflammatory pathway 
(Kobayashi and DeLeo, 2009). Moreover, in the host immune system, neutrophils are 
essential as they can protect the host from rapidly dividing bacteria, yeast and fungal 
infections, possessing microbicidal mechanisms while producing reactive oxygen 
and nitrogen species, releasing proteolytic enzymes and microbicidal peptides from 
cytoplasmic granules (Shaw et al., 2010). In addition, neutrophils capable of 
destroying foreign antigens or pathogens by producing ROS and lytic enzymes while 
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releasing many chemokines recruiting additional neutrophils at the infection site 
(Selders et al., 2017).   
Neutrophils phagocytic activity triggers the release of various cytokines and 
chemokine, including IL-1α, IL-1β, IL-1ε, IL-1RN, IL-6, IL-8, IL-10, IL-12β, IL-15, 
IL-18, CCL2 (MIP1α), CCL3 (MIP1β), CXCL1 (GROα), CXCL2 (MIP2α), CXCL3 
(MIP2β), CXCL12 (SDF1), CCL20 (MIP3α), tumor necrosis factor (TNF)-α, 
vascular endothelial cell growth factor, and oncostatin M (Kobayashi et al., 2005). 
Massive neutrophil influx will lead to the formation of oedema and hemorrhage (Li 
et al., 2016). Study by Suo et al., (2014) revealed that the reduced neutrophil 
numbers in the inflamed tissue has led to a dramatic reduction of oedema formation. 
In addition, the migrating neutrophils participate in the cascade of events leading to 
mechanical hypernociception, by mediating the release of hyperalgesic molecules 
(such as MPO, MMPs, hypochlorite, superoxide anion, and PGE2) capable of 
activating nociceptive neurons and causing pain during inflammatory process (Rosas 
et al., 2017). 
The number of the infiltrated neutrophils peaks in 6-24 hours after injury and 
declines rapidly 72-96 hours after injury (Yang and Hu, 2018). Due to present of 
antimicrobial and pro-inflammatory mechanisms, neutrophils need to return back to 
homeostatic state to avoid unnecessary tissue damage thus neutrophils clearance 
occur through apoptosis and senescent through a negative-feedback loop involving a 
cascade of cytokines, namely the IL-23–IL-17 G-CSF axis (Hajishengallis and 
Hajishengallis, 2014).  Neutrophils apoptosis can be intrinsic (myeloid cell 
leukaemia-1 (Mcl-1)) or extrinsic (FasL, TRAIL and TNF-α) via activation of 
caspase-8 (Wright et al., 2010).  In addition, neutrophils also often phagocytosed or 
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inhibited by macrophages or lymphocytes after digestion of pathogens to minimize 
the tissue damage (Liu et al., 2018). 
2.2.2 Monocytes 
Monocytes are second line defense of innate immune system where they 
migrate to sites of inflammation after neutrophil infiltration and can be sustained for 
days (Ingersoll et al., 2011). Monocytes are bone marrow-derived myeloid cells that 
belong to the mononuclear phagocytic system (MPS), a specialized system of 
phagocytic cells localized throughout the body (Lauvau et al., 2014). Neutrophils are 
capable of inducing the recruitment of other immune cells including monocytes by 
regulating the release of chemo attracting factors, such as cathepsin G and 
azurocidin, and neutrophils also can alter vascular permeability by inducing changes 
in the cytoskeletal structure of endothelial cells, thus promoting the transmigration of 
monocytes (Kumar et al., 2018).  
Following conditioning by local growth factors, pro inflammatory cytokines 
and microbial  products, monocytes escape apoptosis by differentiating into 
macrophages and dendritic cells, cells with a longer life span and can be found in 
almost every single organ (Parihar et al., 2010). During homeostasis and 
inflammation, circulating monocytes leave the bloodstream and migrate into tissues 
in response to natural killer (NK) cell-produced interferon (IFN-𝛾𝛾) and chemokine 
receptor CCR2 and its ligands CCL2 and CCL7, then will further differentiate into 
macrophage or dendritic cell population (Shi and Pamer, 2011; Sprangers et al., 
2016). Macrophages start to present at the site of infection at 24 hours after injury 
and the number of macrophages increases significantly 2 days after injury along with 
the rapid decline of the number of neutrophils (Yang and Hu, 2018). 
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Macrophages are a heterogeneous population of innate myeloid cells involved 
in health and disease (Xuan et al., 2015). They are scavenger cells that phagocytized 
cellular debris, invading microorganisms, neutrophils, and other apoptotic cells 
(Wynn and Vannella, 2016). According to Davies et al., (2013), macrophages have 
been functionally grouped into two classes: the ‘M1-M2 paradigm’. M1 or classical 
activated macrophages (CAM) homing of pro-inflammatory (M1) and M2 or 
alternative activated macrophages (AAM) involves in anti-inflammatory that plays a 
different role in the process of inflammation (Xuan et al., 2015).  
Pro-inflammatory monocytes in mice is characterized by 
Gr1+/Ly6ChighCCR2+CX3CR1low can differentiate into inflammatory macrophages 
and dendritic cells, while anti-inflammatory monocytes (Gr1-/ Ly6ClowCCR2- 
CX3CR1high) perform patrolling functions and differentiate to M2 macrophages 
(Orekhov et al., 2019). In human there are three monocyte subsets: classical 
(CD14high/CD16−), intermediate (CD14high/CD16+), and non-classical 
(CD14low/CD16+) where non-classical monocytes are the most pro-inflammatory in 
response to TLR stimulation (Ong et al., 2018; Gjelstrup et al., 2018). Monocytes 
that are circulating in the blood stream are short-lived and undergo spontaneous 
apoptosis under normal condition (Parihar et al., 2010). Classical monocytes have a 
very short circulating lifespan (mean 1.0 ± 0.26 d) whereas intermediate monocytes 
have a longer lifespan (mean 4.3 ± 0.36 d) and non-classical monocytes have the 
longest lifespan in blood (mean 7.4 ± 0.53 d), before either leaving the circulation or 
dying (Patel et al., 2017).  
2.2.2 (a) Inflammatory Macrophages (M1) 
CAM or M1 macrophages (Figure 2.2) can be activated by 
lipopolysaccharide (LPS) upon interaction with toll like receptors (TLRs) and IFN 
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signaling (Liu et al., 2014). On the other hand, carrageenan can induced TLR 
activation as carrageenan can activate both TLR2 and TLR4 and mediate NF-κβ 
pathway, similar to LPS (Shalini et al., 2015) M1 macrophages are characterized by 
enhanced expression of MHC class II and high production of pro-infammatory 
cytokines (Haloul et al., 2019). In addition, M1 macrophages also can be activated 
by IFN-γ and TNF-α (Yao et al., 2019). 
When the pathogen associated molecular patterns (PAMPs) presented in 
bacteria are recognized by pathogen recognition receptors (TLRs), macrophages are 
activated and producing a large amount of pro-inflammatory mediators like 
cytokines IL-1β, IL-6, IL-12, IL-18 and IL-23, TNF-α, and type I IFN; and several 
chemokines such as CXCL1, CXCL3, CXCL5, CXCL8, CXCL9, CXCL10, 
CXCL11,CXCL13, and CXCL16; CCL2, CCL3, CCL4, CCL5, CCL8, CCL15, 
CCL11, CCL19, and CCL20; as well as CX3CL1; which induce Th1 response 
activation, facilitate complement-mediated phagocytosis, (Lu et al., 2018; Atri et al., 
2018). M1 macrophages also can induce inducible NO synthase (iNOS), the enzyme 
that produces large amounts of NO that is not only cytotoxic, but produces toxic 
metabolites that establish M1 killing machinery and type I inflammation (Ley, 2017). 
It is found that NF-κB and STAT1 are the two major pathways involved in M1 
macrophage polarization and result in microbicidal and tumouricidal functions (Yao 




Figure 2.1 Classical activated macrophages (CAM) (Yao et al., 2019) 
 
2.2.2 (b) Inflammatory Macrophages (M2) 
M2 macrophages (Figure 2.3) are the result of the stimulation of Th2 
signature cytokine interleukin-4 (IL-4) or IL-13 (Yu et al., 2019). M2 macrophage 
polarization can be induced by downstream signals of cytokines IL-4, IL-13, IL-10, 
IL-33, TGF-β, and they also can be activated by up-regulation of cytokines and 
chemokine, such as IL-10, TGF-β, CCL1, CCL17, CCL18, CCL22, and CCL24 (Yao 
et al., 2019). Macrophage M2 polarization involves tyrosine phosphorylation and 
activation of a signal transducer and activator of transcription 6 (Stat6), which 
mediates the transcriptional activation of M2 macrophage-specific genes such as 
arginase 1 (Arg1), mannose receptor 1 (Mrc1), resistin-like α (Retnla, Fizz1), 
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chitinase-like protein 3 (Chil3, Ym1), and the chemokine genes CCL17 and CCL24 
(Yu et al., 2019).  
M2 macrophages secrete anti-inflammatory cytokines like IL-10, CCL18 and 
CCL22 (Genin et al., 2015). In addition, M2 macrophages can produce IL-4 and IL-
13 which could induce M2 polarization in while IL-10 can affect the morphology of 
IL-4 and IL-13 on macrophages, can downregulate the expression of MHC class II 
molecules, and has variable influences on mannose receptor expression, leading to 
decreased fluid-phase and mannose receptor-mediated endocytosis while TGF-β 
could uniquely inhibit inflammation through reducing iNOS-specific activity and 
decreasing iNOS protein production (Bi et al., 2019). Therefore, M2 macrophages is 
important in clearing the apoptotic cells, alleviation of inflammatory responses, and 
promotion of wound healing (Suzuki et al., 2017).  
 
Figure 2.2 Alternative activated macrophages (AAM) (Yao et al., 2019) 
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2.3 NF- κB signaling in inflammation 
NF-κB plays an important role as a mediator of the effects of inflammation 
and oxidative stress upon immune function (Arranz et al., 2010). NF-κB 
transcription factor involves in the inflammatory response by regulating the 
expression of various genes encoding pro-inflammatory mediators such as cytokines, 
chemokine, growth factors and inducible enzymes (Hussein et al., 2013). NF-κB has 
been associated in the pathogenesis of a number of inflammatory diseases, such as 
rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis, 
atherosclerosis  systemic lupus erythematosus, type I diabetes, chronic obstructive 
pulmonary disease and asthma (Liu et al., 2017; Arranz et al., 2010). In addition, 
NF-κB present in the cytoplasm and is consists of five structurally related members, 
including NF-κB1 also known as p50, NF-κB2 also named p52, RelA also named 
p65, RelB and c-Rel, which mediates transcription of target genes by binding to a 
specific DNA element, κB enhancer, as various hetero- or homo-dimers (Liu et al., 
2017). 
Generally, NF-κB present as an active heterotrimer consisting of p50, p65 and 
IκBαsubunits (Brodsky et al., 2010). p65 and p50 exist normally in the cytoplasm as 
an inactive complex by binding to inhibitory factor, IκBα, thereby blocking NF-κB 
nuclear translocation. Upon stimulation with inflammatory stimuli, IκBα is 
phosphorylated by IκB kinase (IKK) and separated from the NF-κB subunits which 
lead to its degradation. The free NF-κB is translocated into the nucleus and acts as 
transcription factor. In the nucleus, NF-κB dimers combine with target DNA 
elements to activate transcription of genes encoding for proteins involved in 
inflammation. In inflammation, activated NF-κB regulates transcription of IL-1b, IL-
6, iNOS, COX-2 and TNF-α (Hussein et al., 2013). 
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There are various stimuli that able to initiate NF-κB pathway, including ligands 
of various cytokine receptors, pattern recognition receptors (PRRs), TNF receptor 
(TNFR) superfamily members, as well as T-cell receptor (TCR) and B-cell receptor 
(Liu et al., 2017). Toll-like receptors (TLRs) are transmembrane receptors that able 
to recognize the triggering factors such as bacteria lipopolysaccharide (LPS) thus 
activate the innate immune system. Figure 2.4 showing binding of 
lipopolysaccharide (LPS) to toll-like receptor 4 (TLR4) that is primarily expressed in 
macrophages initiates several signal transduction pathways, including NF-κB (Shih 
et al., 2018). Similar with LPS, carrageenan up regulated the mRNA and protein 
level expressions of both TLR2 and TLR4, thus activation of TLR-NF-κB signalling 
in carrageenan also can induce inflammation (Shalini et al., 2015).  
 




2.4 Inflammatory Pain 
Nociceptors are receptors on nociceptive primary sensory neurons in the 
peripheral nervous system (Ji et al., 2016). It innervates peripheral tissues including 
the skin, respiratory, and gastrointestinal tracts, which are often exposed to numerous 
harmful stimuli including pathogens. Nociceptors sensory neurons are specialized to 
detect potentially damaging stimuli, protecting the host body by initiating the 
sensation of pain and eliciting defensive behaviors (Chiu et al., 2013). According to 
Omoigui, (2007), pain is currently defined by the International Association for the 
Study of Pain (IASP) as 'an unpleasant sensory or emotional experience associated 
with actual or potential tissue damage, or described in terms of such damage'. 
Inflammatory responses in the peripheral and central nervous systems have been 
associated with the development and persistence of many pathological pain states 
(Zhang and An, 2007).  Pain serves obvious physiological functions, such as warning 
of potentially dangerous stimuli or drawing attention to inflamed tissue (White et al., 
2005).  
Pain can cause hyperalgesia, allodynia and spontaneous pain (Stemkowski and 
Smith, 2012). Hyperalgesia is a condition where the sensitivity to pain is increased 
abnormally, resulting in hypersensitivity due to the sensitised nociceptive nerve 
endings. On the other hand, allodynia is a condition when body experience pain from 
a stimuli that normally do not cause pain. For example touch, light pressure, or 
moderate cold or warmth can cause pain when applied to apparently normal skin. 
Spontaneous pain is the consequence of chronic pain thus resulting in non-evoke 
pain sensation (Stemkowski and Smith, 2012).  
Inflammation are often been associated with pain due to the production of   
mediators such as pro inflammatory cytokines, chemokines, PGE2, and NO mainly 
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by microglial cells and by other non-neuronal cells of the nervous as well as immune 
cells such as macrophages, thus contribute to pain hypersensitivity by activating 
nociceptive neurons in the CNS and in the peripheral nervous system (PNS) 
(Carniglia et al., 2016). Studies by Cui et al., (2000) shown that there was a highly 
significant difference in the number of monocytes/macrophages, IL-6 and TNF-α 
positive cells between allodynic and non-allodynic rats, suggesting that these 
inflammatory components are associated with the development pain. Furthermore, 
macrophages can induce nerves growth factors (NGF) via production of cytokines 
such as TNF-α, IL-6 and IL-1β thus contributes to the generation of neuropathic 
pain.  
According to Zhang and An, (2007), there are abundant of evidence that 
associate pro-inflammatory cytokine produced by activated macrophages with the 
process of pathological pain. For example, IL-1β was found to increase the 
production of substance P and prostaglandin E2 (PGE2) in a number of neuronal and 
glial cells thus results in hyperalgesia. IL-6 involved in microglial and astrocytic 
activation as well as in regulation of neuronal neuropeptides expression thus 
contributes to the development of neuropathic pain behavior following a peripheral 
nerve injury. Another cytokine, TNF-α acts on several different signaling pathways 
through two cell surface receptors, TNFR1 and TNFR2 to regulate apoptotic 
pathways, NF-κβ activation of inflammation, and activate stress-activated protein 





2.5 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 
Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most widely 
prescribed and common drugs used in the world (Burian and Geisslinger, 2005). 
NSAIDs are frequently used for the treatment of signs and symptoms of 
inflammation as well as an antipyretics, analgesics and inhibitors of platelet 
aggregation (Ulrich et al., 2006). The anti-inflammatory action of non-steroidal anti-
inflammatory drugs (NSAIDs) is mediated through their inhibitory effects on 
cyclooxygenase (COX) activity (Mizushima, 2010). 
COX is responsible for synthesis of prostaglandin signaling molecules, which are 
involved in a wide range of physiological processes beyond inflammation. There are 
two major classes of COX enzymes have which are COX-1 and COX-2. COX1 is 
constitutively expressed in many tissues and seems to be relevant for the tissue 
homeostatic functions of prostaglandins, and COX2, which is an inducible form that 
has a role in many inflammatory and proliferative reactions (Ulrich et al., 2006). 
NSAIDs possess anti-inflammatory and analgesic effects by acting as inhibitors of 
COX-2 thus reducing the production of prostaglandin that is responsible for 
hyperalgesic effects (Burian and Geisslinger, 2005). 
Despite of their therapeutic effects, NSAIDs are responsible for 21–25% of 
reported adverse drug events which include immunological and non-immunological 
hypersensitivity reactions (Kowalski et al., 2011). Various side effects have been 
associated with NSAIDs prescription including gastrointestinal bleeding, ulcers, 
ulcer complications and ulcer complications leading to death (Wright, 2002). In 
addition, NSAIDs increased the risk of adverse cardiovascular events for example 
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congestive heart failure, increase blood pressure, myocardial infarction and ischemia 
(Risser et al., 2009).  
2.6 Carrageenan-induced Paw Oedema Model 
Animal models of inflammation and pain have been widely used to study the 
mechanisms of inflammatory pain. There are numerous inflammatory agents or 
irritants can be used to develop inflammatory animal models including complete 
Freund’s adjuvant, carrageenan, zymosan, mustard oil, formalin, capsaicin, bee 
venom, acidic saline, lipopolysaccharide, inflammatory cytokines, and sodium urate 
crystals (Table 2.1) which can results in tissue injury and hyperalgesia in such 
structures as cutaneous/subcutaneous tissues, joints, and muscles (Zhang and Ren, 
2011). As shown in Table 2.2, there are various inflammation and pain model used 
by researchers to study inflammatory diseases that can provide powerful insights into 
the possible underlying pathologies of human diseases and finding of potential 
human therapeutics (Webb, 2014).  
Table 2.1 Comparison of cutaneous/subcutaneous inflammatory pain models 
(Umar Zaman, 2019) 
Chemical Time of Onset Duration 
CFA 2-6 h 1-2 weeks 
Carrageenan 1 h 24 h 
Mustard oil 5 min <1 h 
Zymosan 30 min 24 h 
Formalin phase I <1 min 5-10 min 
Formalin phase II 10 min 1 h 
Bee venom 1 min 96 h 




Table 2.1 Typical animal models of inflammation and autoimmune diseases (Webb, 2014) 
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Joint destruction Mouse 
(rat) 
Most reflective 
of human joint 
pathology 
Respond to NSAIDs/TNF 
inhibitors/IL-1 inhibitors 
Not reflective of all 
human joint pathology-
acute disease model, self-
limiting, limited 
predictability for cell 













Mouse Reflect acute 
phase of disease 
Respond to NSAIDs. P38 
and PDE inhibitors 
Model is acute 
Carrageenan Inflammation Inflammed paw Mouse Generalized IL-1RA, anti-IL-6 Non-specific 
26 
 
paw model oedema inflammation NSAIDs model 
Tail flick Pain No treatment 
required 
Mouse, rat Acute pain 
(burn) 
Very specific for 
analgesic 
Does not reflect 
neuropathic or 
inflammatory pain 








ng MS like 
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Generally a self-limiting 
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Table 2.2. Continued 















trachea and will 
respond to many 
anti-asthmatic 
drugs    
















Useful Can be used for topical 











Mouse Shows most of 
the features of 
Crohn’s diseases 
and ulcerative 
Not always  predictive 
although anti-TNF’s and 
some other drugs work 
here 
Not completely reflective 
of human disease (gut 
flora differences between 
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Mouse Allows detailed 
study of effects 
of gene depletion 
or 
amplification/mu
tation in vivo  
Can uncover new targets 
for therapeutic evaluation  
Amplifies specific gain or 




Primarily used for 
hematologic 
studies of various 
types 
Human immune 
cells can be 
studied in vivo 
reflecting some 
aspects of human 
immunity 








Some aspects of human 
immunity may be studies 
in an in vivo setting 
Not the same physiology 
as in man  
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Carrageenan is a generic name for a family of gel-forming and viscosifying 
polysaccharides, which are obtained by extraction from certain species of red 
seaweeds (Necas and Bartosikova, 2013). Carrageenan is widely used in processed 
food including dairy products, processed meats, infant formula, as well as cosmetics 
and pharmaceutical products where the serves as a thickener, stabilizer, or 
emulsifying agent (Borthakur et al., 2012).  
There are three main types of extracted carrageenan, iota (ι), kappa (κ) and 
lambda (λ) (Figure 2.5) depending on which seaweed it has been extracted from. 
Kappa carrageenan is extracted from species of Kappaphycus such as K. alvarezii 
and K. striatum whereas iota carrageenan is extracted from Eucheuma denticulatum, 
and Lambda carrageenan is primarily extracted from Chondrus crispus. Lambda 
carrageenan that is extracted from Chondrus crispus has been used for decades in 
research for its potential to induce inflammation (Barth et al., 2016). According to 
Radhakrishnan et al., (2003), carrageenan is one of the most commonly used irritant 




Figure 2.4 Chemical structure of carrageenans (Necas and Bartosikova, 2013) 
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Studies by Bhattacharyya et al., (2008) proves that similar with bacterial 
lipopolysaccharide, carrageenan also able to interact with TLR4 receptors thus 
induce the activation of NF-κβ pathways. The carrageenan-induced inflammatory 
cascades by direct binding to TLR4 thus activate NF-κB pathway (Borthakur et al., 
2012).  Therefore, intra plantar injection of carrageenan will results in the 
development of inflammatory response with cardinal signs of inflammation such as 
redness, heat and local hypersensitivity as well as the releasing of various 
inflammatory cytokine and chemokine also infiltration of immune cells (Patil et al., 
2017). 
2.7 Free Radical 
Free radical are the products of normal cellular metabolism and can be defined as 
an atom or molecule containing one or more unpaired electrons in valency shell or 
outer orbit and is capable of independent existence (Bala and Haldar, 2013). The 
unpaired electron of a free radical makes it unstable, short lived and highly reactive 
towards chemical reactions with other molecules (Chakraborty and Ahmed, 2011; 
Kumar and Pandey, 2015). The free radicals are derived from both endogenous 
sources (mitochondria, peroxisomes, endoplasmic reticulum, phagocytic cells) and 
exogenous sources (pollution, alcohol, tobacco smoke, heavy metals, transition 
metals, industrial solvents, pesticides, certain drugs like halothane, paracetamol, and 
radiation) (Phaniendra et al., 2015).  
Normally, free radical protects body from bacteria viruses and other foreign 
substances. When our antioxidant defenses are adequate, damage caused by those 
free radicals is repaired without many consequences. However when excessive 
amount of free radicals generates it can damage proteins, lipids, enzymes and DNA 
that can alter downstream cell signaling and a cause a variety of disease (Khanna et 
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al., 2014). Free radical can be classified into two main groups, reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) (Sun et al., 2017). 
2.8 Reactive Oxygen Species 
ROS comprise both free radicals and other non-radical reactive species. The 
examples for the radicals include Superoxide superoxide (O2•ˉ), oxygen radical 
(O2••), Hydroxyl (OH•), Alkoxyradical (RO•), Peroxyl radical (ROO•), nitric oxide 
(nitrogen monoxide) (NO•) and nitrogen dioxide (NO2•) (Phaniendra et al., 2015; 
Pham-Huy et al., 2008). The non-radical species include hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl), hypobromous acid (HOBr), ozone(O3), singlet oxygen 
(O2), nitrous acid (HNO2), nitrosylcation (NO+), nitroxyl anion (NO-), dinitrogen 
trioxide (N2O3), dinitrogen tetraoxide (N2O4), nitronium (nitryl) cation (NO2+), 
organic peroxides (ROOH), aldehydes (HCOR) and peroxynitrite (ONOOH) 
(Phaniendra et al., 2015).  
ROS/RNS role are both beneficial and toxic to the body because at low or 
moderate levels, ROS/RNS possess beneficial effects on cellular responses and 
immune function meanwhile overproduction of ROS/RNS will generate oxidative 
stress, a deleterious process that can damage all cell structure (Pham-Huy et al., 
2008). Under normal condition, ROS serve several physiological functions, where 
they involve in signaling pathways that modulate physiological processes such as 
inflammation, apoptosis, regulation of smooth muscle tone, and leukocyte adhesion 
to the vascular endothelium (Chakraborty and Ahmed, 2011). 
On the other hand, excessive production of ROS/RNS over a prolonged 
period of time can cause damage to the cellular structure and functions when they 
oxidize protein, lipid cellular constituents and damage the DNA due to high 
oxidizing ability (Mittal et al., 2014). In addition, ROS may induce somatic 
32 
 
mutations, preneoplastic and neoplastic transformations (Hussain et al., 2016). 
Therefore, ROS play an important role in diverse range of degenerative diseases for 
example atherosclerosis, inflammatory joint disease, asthma, diabetes, kidney 
diseases, and degenerative eye disease as well as various cancers due to damaged 
DNA (Biswas et al., 2017; Yang et al., 2018). 
The source of ROS including enzymatic reactions in various cell 
compartments, including the cytoplasm, cell membrane, endoplasmic reticulum 
(ER), mitochondria, and peroxisome, as part of basal metabolic function. They are 
also generated specifically by enzymes such as NOXes (nicotinamide adenine 
dinucleotide phosphate [NADPH] oxidases) and serve a signaling function in the cell 
(Forrester et al., 2018).  
Generally, ROS are involved in the initiation, progression and resolution of 
inflammatory response (Chelombitko, 2018). This is because epithelial cells, resident 
macrophages, endothelial cells, and recruited inflammatory cells, such as neutrophils, 
eosinophils, monocytes, and lymphocytes, produce ROS at the site of inflammation 
by their phagocytic activity (Lee and Yang, 2012). In addition, increasing of NADPH 
oxidases by pro-inflammatory cytokines, such as tumor necrosis factor-a (TNF-α) 
and interleukin-1β (IL-1β) during infection will results in increasing of ROS that 
particularly important as a host defense mechanism but excessive NADPH oxidase 
activation has also been implicated in oxidative stress (Fischer and Maier, 2015; 
Yang et al., 2007). Furthermore, ROS can activate NF-κβ in response to 
inflammatory agonists Forrester et al., 2018).  
2.9 Antioxidant 
Antioxidants are enzyme that reduces the level of ROS/RNS thus counteract 
the overproduction of ROS/RNS (Lei et al., 2015). Antioxidants existed in many 
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dietary natural sources such as vegetables, fruits, and beverages and dietary 
antioxidants such as polyphenols and flavonoids thus can help reducing oxidative 
stress on cellular structure and prevent oxidative damage (Yeung et al., 2019; Zhang 
and Tsao, 2016). Oxidative stress is a cellular phenomenon or condition which 
occurs as a result of physiological imbalance between the levels of antioxidants and 
oxidants (free radicals or ROS/RNS) where the level of antioxidants  have been 
overwhelmed by the free radicals due to excessive production of reactive species 
(Ighodaro and Akinloye, 2018).  
It is important to keep balance between oxidants and antioxidants in order to 
protect cells from oxidative damage that can lead to many chronic diseases, such as 
cancer, diabetes, cardiovascular disease and many more (Zou et al., 2016). 
Antioxidants inhibit the oxidation reaction of free radicals by exchanging one of their 
own electrons with the free radical molecules to stabilize them (Sanchez, 2017). 
Antioxidants can be endogenous and dietary antioxidants such as polyphenol, 
vitamin A for example carotenoids, vitamin E (α-tocopherol), β-glucan, proteins, 
ascorbic acid (vitamin C), glutathione and many more (Sanchez, 2016). 
When endogenous antioxidants are inadequate to remove free radical from 
the body, it becomes important for the body to receive exogenous natural 
antioxidants such as phenolic compounds, secondary plant metabolites that are found 
naturally in all plant materials, including plant based food products (Grzesik et al., 
2018). Study has found that phenolic and flavonoid compounds act as antioxidants 
that exhibits anti-allergic, anti-inflammatory, anti-diabetic, antimicrobial, anti-
pathogenic, antiviral, antithrombotic, and vasodilatory effects due to their ability to 
protect against oxidative diseases, activate or inhibit various enzymes bind specific 
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receptors, and protect against cardiovascular diseases by reducing the oxidation of 
low-density lipoproteins (Huyut et al., 2017).  
2.10 Vitex rotundifolia 
V. rotundifolia is an important coastal and medicinal plant, also known as 
Beach Vitex , a deciduous, sprawling shrub with round leaves and spicy fragrance 
that is widely distributed in coastal areas of Japan, Southeast Asia, Pacific Islands, 
and Australia (Nigam et al., 2018; Chaudhry et al., 2019; Sun et al., 2019). V. 
rotundifolia belongs to the Verbenaceae family of angiosperms, also placed in 
Lamiaceae family, is a low-growing, salt tolerant, shoreline/sea side shrub (Cousins 
et al., 2017; Parkhe and Bharti, 2019; Kim et al., 2020). The diameter of V. 
rotundifolia is around 6-8 feet and 2 inches feet where the leaves are 1-2 inches long 
and round with gray-green to silvery color and has spicy fragrance (Rani and 
Sharma, 2013). Vitex rotundifolia grows 0.5-1.0 m in height; however growth is 
primarily concentrated in a dense mat horizontally, with spreading branches up to 20 
m long and approximately 5 m in width and nodal rooting of the branches contributes 
to this mat-like growth (Banisteria, 2009).  
Various phytochemical constituent (Figure 2.6) can be found in this plants 
including flavonoids, alkaloids, saponins, iridoids, phenolics, mono- and diterpenes, 
α-pinene, α-terpineol, 1,8-cineole and manoyl oxide, phenylnapthalene; 
polymethoxyflavonoids, dehydroabietane, biformene, rotundiferan, vitexicarpin, 
prerotundifuranne and rotundifuranne, aucubin, thunbergol, mussaenosidic acid, 
trans-phytol and sabinene that act as cytotoxic, cell-cycle arrest, apoptosis inducer, 
antioxidant, activation c-Jun N-terminal kinase (JNK), inactivation of NF-κB, and 





Figure 2.5 Phytochemical constituents of Vitex spp. (Nigam et al., 2018) 
 
2.10.1 Medicinal use of V. rotundifolia 
The presence of phytochemical constituents and bioactive compounds that 
exhibits various therapeutic activities determines the medicinal properties of plants 
(Mohammed et al., 2016). V. rotundifolia is has been used as folks medicine because 
most parts of Vitex plants (the leaves, fruits, roots and stems) (Figure 2.7) are known 
to have many medicinal values (Abdul Hakeem et al., 2016). Vitex spp. has been 
used as traditional medicine to treat diarrhoea, gastrointestinal disorders, sprain, 
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rheumatic pain, inflammation, cancer, respiratory infections, migraine premenstrual 
problems, depression, allergy, wounds (Chan et al., 2018); Abdul Hakeem et al., 
2016;). Moreover, V. rotundifolia possessed potent repelling activity, stronger 
antioxidative activity, antiproliferative activity, potential chemopreventive agents, 
antiaging and skin-whitening, antipyretic, analgesic, anti-inflammatory functions, 
bacteriostasis and antimalarial activity (Rani and Sharma, 2013). 
2.10.1 (a) Leaves 
The leaves of V. rotundifolia produces thick, waxy cuticle 1-2 inches long 
and round with gray-green to silvery color and has spicy fragrance containing large 
amounts of diverse n-alkanes where these compounds are transferred to the surface 
of sand particles where they cause intense hydrophobicity in the substrate (Cousins et 
al., 2017; Rani and Sharma, 2013). Leaves of V. rotundifolia have been used as 
insects repellent due to the present of rotundial that act as insect repellent that are 
more powerful than deet (Cousins et al., 2017). Methyl-p-hydroxybenzoate from the 
leaf of V. rotundifolia exhibited 100% mortality against the larvae of of Culex 
quinquefasciatus and Aedes aegypti explained the effectiveness of the leaves as 




Figure 2.6 Leaves, flower, and fruits of V. rotundifolia (Chan et al., 2016). 
 
2.10.1 (b) Roots 
V. rotundifolia roots characteristics is nodal rooting that allows the plant to 
form dense mats that spread from mother plants to distances of more than 10 m and 
roots and stems are capable of rapid regeneration (Cousins et al, 2010). The roots of 
V. rotundifolia are used to treat febrifuge, cough and fever while the stems of V. 
rotundifolia was proven to be very toxic against cultures of several cell line and the 
aerial parts of this plant are useful in diabetes treatment (Abdul Hakeem et al., 2016).  
2.10.1 (c) Stems 
Young stems of V. rotundifolia are square and green or purple, fleshy at the 
tips, and as the stems mature, the stems develop into round, brown, and woody where 
the bark will crack and fissure with age while the branches from running stems are 
upright (Cousins et al., 2017). The stems of V. rotundifolia has been found to 
exhibits cytotoxic effects against cultures of several cancer cell lines as well as an 
important anti-feeding activity against the insect pest Spodoptera frugiperda (Meena 
et al., 2011).  Leaves and bark of V. rotundifolia contain flavones, artemetin, 
essential oil, 7-dimethyl artemetin, friedelin and some alkaloids and non-flavonoids 
(Parkhe et al., 2019).  
2.10.2 Fructus viticis of V. rotundifolia 
The fruit of V. rotundifolia (also known as Fructus viticis) are small succulent 
drupes, globular or ovoid of 0.2-2 cm size (usually smaller than 2 cm), with hardened 
endocarp that is divided in four pyrenes, each one with a seed and the ripe pulp of 
these fruits is characterized by dark-purple to brown colors (Pío-León et al., 2011). It 
has been used as traditional medicinal plants for the treatment of anemopyretic cold, 
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headache, rheumatism, cancer and premenstrual disorder (Fang et al., 2016). 
Moreover, Fructus viticis has been used as traditional Chinese medicine with 
analgesic properties to provide efficient relief of migraine (Wen et al., 2019).  
Studies found that Fructus viticis substantiated the anti-tumor properties in 
diverse range of human cancer cells and their xenograft models in mice due to 
presence of large amounts of flavonoids, including casticin, luteolin, apigenin, 
isoorientin, hesperidin, isovitexin and so on (Cao et al., 2016).  Other medicinal uses 
of Fructus viticis including alleviating cold-heat between tendons and bones, damp 
arthralgia and muscular spasms, eyesight-improving, teeth-strengthening, nine-
orifices benefiting, expelling white worms, losing weight and delaying senility, 
eliminate the symptoms of eye-swelling, eye-itching and eye-drying, delay fatigue, 
alleviating pyrexia, eyes and gums pain, giddiness and headache, used as used for 
sedation, relieving pains and diminishing inflammation (He et al., 2019). 
2.10.3 Pharmacology use and bioactivity of Fructus Viticis 
Several kinds of compounds, including diterpenoids, flavonoids, lignans, 
iridoid and phenolic glucoside can be found in the fruits of V. rotundifolia (Fructus 
viticis) (Wang et al., 2014). Bioactive compound of Fructus viticis exhibits various 
pharmacology activities such as anti-cancer, anti-inflammatory, anti-allergy, 
antioxidants, anti-nociceptive, and antibacterial (Cousins et al., 2017). Fructus viticis 
contains flavonoids such as artemetin, quercetagetin, 5,3΄-dihydroxy-6,7,4΄-
trimethoxyflavanone and casticin, where casticin is the primary active compound, 
and many researches has been conducted to study chemical constituents of the 




Casticin (3’,5-dihydroxy-3,40 ,6,7-tetramethoxyflavone) also known as 
vitexicarpin or casticine, has shown anti-cancer properties, anti-inflammatory 
properties as well as anti-asthmatic, tracheospasmolytic, analgesic, anti-
hyperprolactinemia, immunomodulatory,  opioidergic, oestrogeni,, anti-angiogenic, 
antiglioma, lung injury protection, rheumatoid arthritis amelioration and liver fibrosis 
attenuation activities (Chan et al., 2018). 
Polymethoxyflavonoids of Fructus viticis (vitexicarpin, luteolin and 
artemetin) were found to induce apoptosis in human myeloid leukemia cells 
(Chaudhry et al., 2019). In addition, diterpenoids that were isolated from Fructus 
viticis has significantly inhibited nitric oxide (NO) production in lipopolysaccharide 
(LPS)-stimulated RAW 264.7 cells thus involves in anti-inflammatory activities 
(Yao et al., 2016). Furthermore, previous studies has found that casticin could 
suppress the inflammatory effect by blocking the NF-κB and MAPK pathways in 
LPS-induced RAW264.7 macrophage cells and decreases the levels of eotaxin and 
reduces eosinophil migration in IL-1β-stimulated A549 human lung epithelial cells 









Chemicals used in this study are shown in Table 3.1 below. 
 
Table 3.1 Chemicals used in this study 
Chemicals Brands 
Fructus Viticis methanolic crude 
extract 
Extracted and processed by 
Universiti  
Malaysia Terengganu (UMT) 
λ-carrageenan Sigma-Aldrich, UK 
Sodium Pentobarbital 20% Dorminal, Holland 
10 % Buffered Formalin Leica Biosystem Richmon 
Ethanol HmbG Chemicals 
PBS Oxoid, UK 
Saline - 
Butylated hydroxytoluene (BHT)  Sigma-Aldrich, UK 
 
3.1.2 Apparatus 
Apparatus used in this study were 25 G (1 inch) and 27 G (1/2 inch) needle, 1 
cc/mL and 3 cc/mL syringe, analytical weighing scale, dissecting set, gloves, masks. 
3.1.3 Instrument 
Rat-tail cuff blood pressure measuring system (IITC Life Science, Mouse Rat 
Blood Pressure (MRBP) System), EDTA vacutainer tube, Randall-Selitto analgesio 
tester (Ugo Basile Analgesy-Meter). 
3.2 Animals 
Animal ethics was approved by the USM Institutional Animal Care and Use 
Committee (USM IACUC) with the ethical approval number: 
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USM/IACUC/2019/(117)/(983) (Appendix A). There were 30 male Sprague-Dawley 
(SD) rats supplied by the Animal Research and Service Centre (ARASC), Universiti 
Sains Malaysia, Health Campus, Kelantan. Animals were received at 6 weeks old, 
their weight ranged between 140-190 g. The rats have been acclimatized in holding 
facility for 14 days before starting the experiment. The rats were placed in pair inside 
a cage in a well-ventilated room. The rats were maintained under standard laboratory 
condition of temperature between 24-28ᵒC, relative humidity 60-70% and 12-hour 
light/dark cycle and were given standard commercial pellet diet and water ad libitum. 
The experiment was conducted when the rats at 8 weeks old, weighing between 180-
250 grams. 
3.3 Experimental design 
Based on previous study by Gainok et al., (2011); Santos Nogueira et al., 
(2012) and Rivat et al., (2002), carrageenan-induced inflammatory pain and 
nociception test using Randall-Selitto test has been conducted within time interval 
until 24 hour of testing. Recommendation of total animal number in each test group 
should be 6-8 animals per group in order to produce valid and precise data and also 
to reduce possible variability of pain measurement in each animal (Santos Nogueira 
et al., 2012). 
 
Table 3.2 Design of treatment and group of animals 
Group Treatment No of Animals (n)  
A Vehicle-DMSO (50 µl) + Saline (100 µl) 6 
B Vehicle-DMSO (50 µl) +  2% λ-
Carrageenan (100 µl) 
6 
C 50 mg/mL Extract (50 µl) + Saline (100 
µl) 
6 
D 50 mg/mL Extract (50 µl) + 2% λ-
Carrageenan (100 µl) 
6 
E 100 mM LNMMA (50 µL) + 2% λ-
Carrageenan (100 µl) 
6 




3.4 Carrageenan-induced inflammation and treatments  
3.4.1 2% λ-carrageenan solution 
Carrageenan solution was prepared by mixing 0.2 g of λ-carrageenan in 10 
mL of distilled water to produce 10 mL of 2% λ-carrageenan. The mixture was fully 
dissolved in 65°C of water bath until the solution become soluble and no clump.  The 
solution was kept in room temperature before using and can be kept up to 6 months.  
3.4.2 Plant extracts  
Treatment of 50 µL of extract is needed for each rats thus to ensure the 
treatment is sufficient, 3000 µL of treatment was prepared. In order to prepare 3000 
µL of 50 mg/mL of treatments, 150 mg of extract was diluted in 3000 µL of 
Dimethyl Sulfoxide (DMSO) and was mixed well until fully dissolved.  
3.5 Animals experimentation 
In vivo experiment was started by measuring all the basal reading of the rats 
including blood pressure, paw thickness as well as pain threshold prior to treatment 
and inflammation creation using carrageenan injection. For anesthetic agents, 20g/kg 
of sodium pentobarbital was given (i.p.)  and once animals were fully anesthetized, 
50 µL of treatment either Vehicle (DMSO), 50 µL of 50 mg/mL extract or LNMMA 
(NG-monomethyl-L-arginine) were administered by injection, subcutaneously (s.c) 
into intra plantar of right hind paw (ipsilateral). The treatment should be given 30 
minutes prior to the induction of inflammation thus 100 µL of 2% λ-Carrageenan 
was injected subcutaneously (s.c.) into ipsilateral 30 minutes after administration of 
treatment to initiate inflammatory response.  
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3.6 Blood pressure 
Blood pressure was taken to ensure the pain caused by carrageenan-induced 
paw oedema only results in peripheral and localized pain and not central and 
systemic pain (Necas and Bartosikova, 2013). Blood pressure of the animals was 
measured using Mouse Rat Blood Pressure (MRBP) System with non-invasive tail 
cuff method (Figure 3.1). Systolic reading (Figure 3.2) was taken triplicates at 
predetermined time (basal, 30 minutes, 2,6,12 and 24 hours post-carrageenan/saline 
injection) to reduce stress experienced by the animals. During the habituation, the 
animals were acclimatised with the restrainer for a week to familiarise the animals 
with the procedure. The restrainer was covered with a cloth to make them calmer 
during the reading process.  
 







Figure 3.2 Systolic reading of MRBP system 
 
3.7 Paw oedema measurement  
Paw swelling or oedema is one of the cardinal sign of inflammation thus 
measuring the paw thickness. It is a useful method in assessing inflammatory 
response as well as examining the ability of the treatment to reduce or prevent the 
development the carrageenan-induced paw oedema (Sarkhel, 2016). Paw oedema of 
the rats were measured using digital vernier caliper with  accuracy of ± 0.2 mm/0.01 
at predetermined time (Basal, 30 minutes, 1, 2, 4, 6, 8, 12, 24 hours) post-
carrageenan/saline injection according to assigned group. The rats were restrained 
properly by gripping the back skin firmly and securely to reduce stress thus animals 
can remain calm throughout the procedure. The measurement was taken by placing 
the vernier caliper around the paw oedema between the bump as shown in Figure 3.3 






Figure 3.3 Measurement of paw oedema using digital vernier caliper 
 
3.8 Randall-Selitto Mechanical Hyperalgesia test 
Due to the releasing of various inflammatory mediators during inflammation, 
the sensitivity to pain increased and caused hyperalgesia.  Various methods can be 
used to assess central antinociceptive and peripheral activity in animals and of the 
method is Randall-Selitto test (Porto et al., 2013) and in this experiment, we used the 
Ugo Basile Analgesy-Meter (Figure 3.4). Randall-Selitto is an instrument that has 
been described as the most predictive of animal models of acute pain (Gainok et al., 
2011). Randall-Selitto or paw pressure test was developed as a tool to assess 
response thresholds to mechanical pressure stimulation and is often considered a 
measure of mechanical hyperalgesia (Deuis et al., 2017). For this experiment, 
pressure was applied to the ipsilateral until the animal withdrew or vocalized pain, at 
which the weight applied during paw withdrawal was recorded. The maximal amount 
of pressure withstood by the animal was limit to 200 mg to avoid any injuries or 
tissue damage to the paw which could cause severe pain to the animal. The 
measurement was taken at predetermined time (basal reading, 30 minutes and at 1, 2, 
4, 6, 8, 12, 24 hours post carrageenan/saline injection) for 3-4 times at one specific 





Figure 3.4 Ugo Basile Analgesy-Meter Randall-Selitto test  
 
3.9 Anaesthesia and Euthanasia   
Sodium pentobarbital has been used as anaesthetic agents in this study. For 
anaesthesia, 200 mg/kg of sodium pentobarbital stock solution was diluted using 
DMSO to produce 20 mg/kg of working solution (calculation shown in Appendix B). 
Intra-peritoneal (i.p) injection of 20 mg/kg of sodium pentobarbital prior to treatment 
and carrageenan injection into the rat hind paw able to produce 20-35 min of 
anesthesia. The rats were monitored accordingly after the injection of anesthesia to 
ensure there is no excessive of cardiac and respiratory functions or insufficient 
anesthesia. After 24 hours post carrageenan injection the animals were euthanized 
using 60 mg/kg sodium pentobarbital that was prepared from stock solution 200 
mg/kg. The animals were injected 60 mg/kg of sodium pentobarbital intra-
peritoneally (i.p) and the animals were monitored to confirm death. The death of the 
rat was confirmed by assessed by pedal reflex in which the paw of the rat was 
pinched firmly to ensure the rat was no longer experience pain. The heart beat and 
the respiratory pattern also were monitored to confirm death before the cardiac 
puncture and tissue collection can be made. 
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3.10 Haematology (Full blood count) 
To further investigate the effects of carrageenan and treatment on immune 
cell, blood sample of each rats after 24 hours was collected and sent to BP 
Laboratory Sdn Bhd. Approximately 5 mL of blood was withdrawn from cardiac 
puncture and was transferred immediately into EDTA vacutainer blood collection 
tubes. Once transferred to the tubes, the tube was tilted to ensure the blood will not 
clot. Three blood samples (n=3) from each group were collected and were sent to B.P 
Clinical Lab Sdn Bhd Kota Bharu, Kelantan, Malaysia for full blood count (FBC) 
analyses. 
3.11 Sample collection 
Once the death of the rat was confirmed, the experiment was preceded with 
ipsilateral paw sample collection. The paw sample was harvested by slicing the 
paw’s skin with scalpels. Figure 3.5 shows the dissecting area of the rat hind paw. 
Three harvested samples (n=3) from each treatment group were kept in cryotubes 
and stored at -80ᵒC for nitric oxide (NO) and TNF-alpha determination in paw while 
the other three samples (n=3) from each group were fixed into 10% buffered 
formalin for histology analysis 
 




3.12 Antioxidant Assay Using DPPH Free Radical Scavenging 
DPPH free radical scavenging assays allow the assessment of free radical 
scavenging ability of plant extracts (Rahman et al., 2015). The ability of the plant 
extract to donate hydrogen atom was determined by the decolorization of methanol 
solution of 2,2-diphenyl-1-picrylhydrazyl (DPPH). DPPH produces violet/ purple 
color in methanol solution and fades to shades of yellow color in the presence of 
antioxidants. DPPH solution was prepared by diluting 0.003 g of DPPH in 100 mL of 
methanol and 2.4 mL of this solution was mixed with 1.6 mL of Fructus Viticis 
methanolic crude extract in 96 well plates. Samples were incubated in the dark for 
approximately 30 minutes. The changes of colour from purple to yellow was 
determined by using spectrophotometer at wavelength 517 nm as shown in Appendix 
C. Absorbance decline by DPPH solution was used as an indication for high 
antioxidant activity. The percentage antioxidant activity was calculated using the 
given formula:   
 %DPPH scavenging = [(𝐴𝐴0 − 𝐴𝐴1)/ 𝐴𝐴0)] x 100  
𝐴𝐴0= absorbance of the control, 𝐴𝐴1= absorbance of the extract together with DPPH. 
Butylated hydroxytoluene (BHT), Gallic acid, Quercetin and Ascorbic acid were 
used as standard and 𝐼𝐼𝐼𝐼50 value of each extract was measured. Comparison of 
antioxidant of methanolic crude extracts of Fructus Viticis was made.   
3.13 Statistical Analysis 
All data are presented as mean value ± standard error mean (S.E.M). 
Comparisons of all data between groups were done using Graph Pad Prisms Version 
7. Paw oedema, pain and blood pressure data were analyzed using two-way 
ANOVA. Meanwhile, full blood count analysis and antioxidant activity was 
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analyzed by using one-way ANOVA with multiple comparison where is appropriate. 







3.14 Chemicals, apparatus, instrument and procedures that will be 
conducted/ Not Complete 
3.14.1 Chemicals 
 
Table 3.3 Chemicals that will be used in this study 
Chemicals Brands 
Xylene Merck 
Ethanol HmbG Chemicals 
Paraffin wax Leica Biosystem Richmond 
Hematoxylin  Merck 
Eosin Merck 
DPX R & M Marketing Essex, UK 
 
3.14.2 Apparatus 
Gloves, masks, slides rack, coplin jar, dropper and glass slide 
3.14.3 Instrument 
Instrument that will be used are tissue processor (Leica, U.S), paraffin 




Paw tissues that were harvested from three animals for each group (n=3) was 
fixed in 10% buffered formalin for at least 48 hours and stored at room temperature. 
Tissues will be dehydrated in a series of alcohols before being cleared in xylene and 
infiltrated with paraffin at 60ᵒC by using paraffin dispenser. The tissue will be 
processed by using tissue processor for overnight by using automated tissue 
processor (Leica, U.S). Blocks will be sectioned with thickness of 4 μm using rotary 
microtome and sections will be mounted onto Mayer’s albumin coated glass 
microscope slides. The sections will be stained with hematoxylin and eosin (H&E) 
where hematoxylin will stain cell nuclei and eosin will stain most of the cytoplasmic 
components thus allow the differentiation of various immune cells.  Staining 
procedure starting by submerging the sides into haematoxylin solution for 6 minutes 
then wash with water for 5 minutes. Then immerse the slides into 0.1% acid alcohol 
solution to decolorize and wash again in running tap water for 5 minutes. Next, the 
slides will be immersed in 1% eosin for 2 minutes. Dehydrate the slides by 
immersing it into absolute ethanol (100 % ethanol). The slides will be submerged 
into absolute xylene for 4 minutes before observing under a light microscope and 
finally a coverslip is placed on slide and mounted using DPX mounting medium. 
3.14.5 Quantify infiltrated cells using Image-J software 
Quantification of infiltrated cells to the paw oedema will be done using 
Image-J (National Institutes of Health and Laboratory for Optical and Computational 
Instrumentation (LOCI), University of Wisconsin). This software allows user to turn 
images into quantifiable data. All original photomicrographs (RBG format) of 
hematoxylin and eosin stained paw tissues sections at 10X magnification will be 
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analyzed. The quantity of infiltrated inflammatory cells will be quantified at the 
specific area.  
3.14.6 Determination of Nitric Oxide in Paw Tissues using Griess Assays 
The harvested ipsilateral paws from three animals for each group (n=3) will 
be used for assessing nitric oxide production using Griess method.  On the day of 
processing, the harvested paws that were kept in cryopreserved vial tube and stored 
in -80ᵒ will be weighed individually for 100 mg before placing in 500 µL of sterile 
phosphate buffer solution (PBS), pH 7.4 (Gautam et al., 2014),. Paws tissue will be 
homogenized using electrical homogenizer followed by centrifugation at 3000 rpm 
for 15 minutes and the supernatant will be used for final processing. 100 µL of 
supernatant will be taken in each well of a 96 well plate will followed by 100 µL of 
Griess reagent. The plate then will be incubated in a dark for 15 minutes and the 
presence of NO in each sample will be read at wavelength of 540 nm using UV-
Spectrophotometer The reading of each sample then will be used to determine the 
concentration of NO based on NO standard curve and for converting absorbance 
readings to nitrite concentration.  
3.14.7 Statistical Analysis 
All data will be presented as mean value ± standard error mean (S.E.M). 
Comparisons of all data between groups will be done using Graph Pad Prisms 
Version 7.Comparison of nitric oxide measurement and quantification of 
inflammatory cells in tissue will be analyzed by using one-way ANOVA with 
multiple comparison where is appropriate. P values of <0.05 will be considered 








4.1 Gross Observation of Paw Oedema  
 Initially all rats showed normal paw appearance with no sign of inflammation 
such as redness, heat, oedema and pain with average of basal reading of paw 
thickness 4.9 ± 0.06 mm. At the beginning of vehicle+saline injection, all rats in the 
group developed minor oedema due to the introduction of needles into the hind paws 
and resolved to normal size after 24 hours as shown in Figure 4.1 (B). As expected 
animals injected with DMSO+2% (w/v) λ-carrageenan developed massive oedema 
with clear cardinal sign of inflammation which are redness, heat, swelling and sign of 
pain even after 24 hour post injection as shown in Figure 4.1 (C). Despite of that, rats 
that were treated with Fructus viticis extract (50 mg/mL extract + carrageenan) 
seems to have delay in the oedema development compared DMSO + carrageenan 
treated group which developed severe oedema. In addition, animals that received 50 
mg/mL extract + carrageenan treatment shows less severe inflammatory sign 
compared to carrageenan group as shown in Figure 4.1 (E). Meanwhile, LNMMA + 
carrageenan treated rats also developed massive oedema which is comparable to 






Figure 4.1 Gross observation of rat hind paws at 24 hours post injection with treatments. (A) Comparison between ipsilateral (injected) and 
contralateral (non-injected) paws. (B) Ipsilateral paw of vehicle + saline. (C) Ipsilateral paw of DMSO + 2% λ- carrageenan showing intense 
inflammation manifested by severe oedema. (D) Ipsilateral paw of 50 mg/mL extract + saline. (E) Ipsilateral paw of 50 mg/mL extract + 
carrageenan showing less inflammation. (F) ipsilateral paw of LNMMA +  carrageenan. 
Ipsilateral Contralateral 
Oedema 
A B C 
E D F 
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4.2 Paw oedema 
In this study, the development of paw oedema after treatment/carrageenan 
injection was investigated for 24 hours. Results revealed that the measurement of 
normal paw thickness of all rats before injection of treatment/carrageenan was in 
average of 4.2-5.4 ± 0.06 mm Generally, most of paws were having swollen paw 
after 30 minutes of  vehicle/treatment+saline/carrageenan injection which due to 
small injury caused by injection needle and administration of fluid (150 ul). Paws 
treated with DMSO+saline started to resolved from 1 hour (6.3 ± 0.4 mm) and the 
paw thickness was maintained until 24 hours (5.5 ± 0.3 mm) with no obvious 
cardinal signs of inflammation as shown in Figure 4.2. In this study, Fructus viticis 
crude extract that was used as treatment did not cause any significant inflammation 
with no significant alteration of paw oedema at all-time point when compared to 
control (DMSO+vehicle) as shown in Figure 4.2. As expected, injection of 2% λ-
carrageenan has produced a massive oedema which manifested by the increasing of 
paw thickness at all-time points until 24 hours. The paw thickness injected with 
carrageenan increased almost 50% at 24 hours (8.4 ± 0.2 mm; p<0.0001) when 
compared to the basal reading (5.0 ± 0.1 mm). Interestingly, in this study, we have 
demonstrated that rats that received 50mg/ml of Fructus viticis crude extract prior to 
carrageenan injection has showed a significant (p<0.01) delayed of oedema 
development in paws when compared to paw of rat injected with 
DMSO+Carrageenan at 4 hours (Extract+Carr: 8.7 ± 0.2mm vs DMSO+Carr: 9.9 ± 
0.2 mm) and 6 hours (Extract+Carr: 8.7 ± 0.3 mm vs DMSO+carr: 9.9 ± 0.2 mm). 
However, after 8 hours to 24 hours there is no significant effect of anti-inflammatory 
activity of the extract when compared to the DMSO+carrageenan group as shown in 
Figure 4.2 and Figure 4.3.  
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LNMMA is nitric oxide synthase inhibitor that is expected to reduce the 
development of inflammatory mediator nitric oxide (NO). However, in this study, we 
have demonstrated that LNMMA did not cause any significant reduction of paw 
oedema caused by the carrageenan. There was no significant difference when 


































Figure 4.2 Comparison of mean paw thickness (mm) of the rats treated with 
different treatment at different time interval for 24 hours. Paw oedema was measured 
using digital vernier caliper. Carrageenan injection has results in enormous paw 
oedema at all-time point when compared to saline group. Extracts exhibits anti-
inflammatory effect by delaying the paw oedema and significantly (aP<0.01) 







Figure 4. 3 Representative of paw thickness measurement at 24 hours post treatments injection by using digital vernier 
caliper; A: DMSO + saline, B: DMSO + carrageenan, C: 50 mg/mL extract + saline, D: 50 mg/mL extract + carrageenan, E: 







4.3 Pain behaviour 
Apart of evaluating the oedema development, in this study, the effect of 
carrageenan/treatment to the development of pain (nociception) in the hind paw was 
also investigated. Generally, the measurement of mechanical nociception threshold 
for all rats before experimentation was ranged from 107.5-200.0 g (168.8 ± 5.4 g). 
At the beginning of vehicle/treatment+saline/carrageenan injection, the rats 
probably experienced pain from the introduction of the needle thus all rats showed 
reducing in mechanical nociception threshold. However, mechanical nociception of 
rats treated with DMSO + saline started to resolved from 1 hour (161.7 ± 13.7 g) and 
the pain threshold was maintained until 24 hours (154.7 ± 16.0 g). As expected, 
injection of 2% λ-carrageenan results in decreasing of mechanical nociception 
threshold at all-time points until 24 hours. Pain threshold of the rats injected with 
carrageenan decrease almost 50% at 24 hours (81.24 ± 10.4 g) when compared to the 
basal reading (147.2 ± 13.1 g). Interestingly, in this study, we have demonstrated that 
rats that received 50mg/ml of Fructus viticis crude extract prior to carrageenan 
injection has showed a significant (p<0.05 & p<0.01) increased of mechanical 
nociception threshold (resolution of pain) when compared to rats injected with 
DMSO+Carrageenan at 1 hour (Extract+Carr: 123.7 ± 9.1 g vs DMSO+Carr: 63.6 ± 
8.7 g) to 6 hours (Extract+Carr: 97.0 ± 9.7 g vs DMSO+Carr: 37.6 ± 3.9 g). 
However, after 8 hours to 24 hours there was no significant analgesic effect of the 
extract when compared to the DMSO+carrageenan group as shown in Figure 4.4. 
Fructus viticis crude extract that was used as treatment did not cause any significant 
increase in pain as there is no significant reduction of mechanical nociception 




Nitric oxide is one of the inflammatory mediators that will sensitise nociceptor 
neuron thus will results in pain. Since LNMMA is nitric oxide synthase inhibitor, the 
rats treated with LMNNA are expected to reduce pain thus increase the pain 
threshold. However, there is no significant difference of pain threshold of rats in 
LNMMA + carrageenan group when compared with DMSO + carrageenan group.  
 
 
Figure 4.4 Comparison of mean mechanical nociception threshold (g) of rats 
treated with different treatment at different time interval The mechanical nociception 
threshold were measured using Ugo Basile Analgesy-Meter of Randal-Selitto. 
Fructus viticis extracts produces analgesic effect by delaying acute pain at certain 
time points which are from 1 to 6 hours aP<0.01 & bP<0.05 when compared with 
DMSO + carrageenan. . 
 
4.4 Blood pressure 
Systolic blood pressure of the rats at different time intervals was ranged 
between (80-180 mmHg). The result of systolic blood pressure shows that there were 
no significant different between all groups of the animals at all-time interval (Figure 
4.5). These indicate that there were no systemic and centralize pain experienced by 
the rats. The rats only experienced peripheral and localize acute pain as a result of 















































Figure 4.5 Comparison of mean systolic blood pressure at different time intervals. Blood pressure of all rats were measured using the Mouse 
Rat Blood Pressure (MRBP) non-invasive tail cuff method. No significant different in blood pressure measurement in comparison between all 













































4.5 Full blood count (FBC) 
As shown in Figure 4.6, there were no significant different in total red blood 
cells, hemoglobin,  hematocrit-packed cell volume (HPCV), mean corpuscular 
volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), red cell distribution width (RDW) and platelet 






Figure 4.6 There are no significant different in total RBC, hemoglobin, HPCV, MCV, MCH, MCHC, RDW and platelet between different 



































































































































































































































































































































































4.5.1 Effects of the treatment on total white blood cells  
Full Blood Count (FBC) analysis revealed that DMSO+carrageenan injection 
in the paw had cause a significant (P<0.05) elevation of white blood cells (WBC) 
(8.4 ± 1.0 %) when compared to control rats (DMSO+Saline) (3.7 +0.4 %). 
However, there was no significant reduction of WBC in the rats treated with 
50mg/mL extract + carrageenan (8.2 ± 0.8 %; p<0.05) when compared to 
DMSO+Carrageenan and the WBC counts was significantly higher when compared 
to control group.  No significant different of WBC in the extract+saline and 
LNMMA+Carrageenan when compared to control group as shown in Figure 4.7.  
 
Figure 4.7 The effect of treatment and carrageenan on total white blood count. 
Carrageenan has caused a significant increase of the total white blood count when 
compared to DMSO + Saline treated rats. Data are presented as mean values of WBC 

















































4.5.2 Effects of the treatment on neutrophil 
Statistical analysis on neutrophils count in blood showed no significant 
difference among groups at 24 hours post injection. However, result showed 
elevation in percentage of neutrophils in blood of carrageenan-induced rats when 
compared to control group. neutrophils count seems to be higher in DMSO + 
carrageenan (48 ± 15.1 %), 50 mg/mL extract + carrageenan (43 ± 13.8 %) and 
LNMMA + carrageenan (41 ± 6.7 %) treated rats compared to DMSO + saline 
(12.3% ± 2.2 %) as shown in Figure 4.8. 
 
Figure 4.8 The effect of treatment and carrageenan on neutrophils. There is no 
significant difference among groups. However carrageenan-induced rats show 
elevation in percentage of neutrophils in blood when compared to DMSO + Saline 
treated rats.  
4.5.3 Effects of the treatment on monocyte  
Full Blood Count (FBC) analysis revealed that DMSO+carrageenan injection 
in the paw had cause a significant (P<0.0001) elevation of monocytes (10.0 ± 0.6 %) 
when compared to control rats (DMSO+Saline) (2.3 +0.3 %). Interestingly, analysis 














































monocytes counts between the treatment, Frutus viticis extract + carrageenan (4.7 ± 
0.7 %) and carrageenan group, DMSO + carrageenan (10.0 ± 0.6 %)  as shown in 
Figure 4.9. In addition, Fructus viticis extract did not cause elevation of monocytes 
counts in FBC analysis as there was no significant alteration of monocytes in the 
Extract+saline (2.67 ± 0.89) when compared to DMSO+Saline (2.33 ± 0.33) . 
Furthermore, LNMMA + carrageenan treated rats showed a significant (p<0.0001) 
reduction of monocytes count (2.3 ± 0.8 %) when compared to carrageenan group.  
 
Figure 4.9 Effect of treatments on the infiltration of monocytes at 24 hours post 
carrageenan or saline injection. DMSO + carrageenan treated rats thus results in 



















































4.5.4 Effects of the treatment on lymphocyte, eosinophils and basophils 
As shown in Figure 4.10, there was no significant difference in the infiltration 
of lymphocytes and eosinophils at 24 hours post carrageenan or saline injection 
despite of different in treatments. Moreover, there was no eosinophils infiltration in 
DMSO + carrageenan and LNMMA + carrageenan treated rats while eosinophils 
percentages in other group were ranged between 1-3 % (1.6 ± 0.3 %). On the other 
hand, average lymphocytes counts in all animals were between 44-87 % (69.8 ± 3.2 
%). From the FBC analyses, no basophils were detected from the whole blood 
collected at 24 hours post saline or carrageenan injection.  
 
 
Figure 4.10 Effect of treatments on the infiltration of lymphocytes (A) and 
eosinophils (B) from whole blood at 24 hours post carrageenan or saline injection. 
No significant effect of treatments on the lymphocytes and eosinophils count in the 
whole blood. 
4.6 DPPH Antioxidant Activity of Fructus viticis methanolic extract 
The antioxidant activity of the Fructus viticis methanolic extract was measured 
by the ability to scavenge DPPH free radicals and was compared with the standard 
BHT. As expected the BHT showed excellent radical scavenging activities with 




























































































(78.82%) at 1 mg/mL. IC50 for BHT and extract was 0.145 mg/mL and 0.365 mg/mL 
respectively.   
 
Table 4.1 DPPH radical scavenging activity of Fructus viticis methanolic 

































9.26 ± 1.65 
 
8.524 ± 0.00 
0.0312 
 
11.15 ± 1.17 
 
16.62 ± 0.00 
0.0625 
 
16.06 ± 1.37 
 
32.14 ± 0.00 
0.125 
 
22.91 ± 1.04 
 
46.76 ± 0.00 
0.25 
 
35.23 ± 0.19 
 
62.08 ± 0.00 
0.5 
 
60.95 ± 4.90 
 
76.51 ± 0.00 
1 78.82 ± 7.43 
 




Figure 4.11 Comparison of antioxidant activity of Fructus viticis methanolic crude 
extracts at different concentration. The antioxidant assay was done by using DPPH 
radical scavenging assay. Determination of 50% inhibition concentration (IC50) for 





4.7 Expected Results 
 
4.7.1 Effects of the Treatment on Nitric Oxide (NO) Concentration in Paw 
Tissues Collected at 24 Hours Post Saline or Carrageenan Injection 
NO is one of the important mediator in acute and chronic inflammation is 
generated via the oxidation of the terminal guanidino nitrogen atom of L-arginine by 
the enzyme, nitric oxide synthase (NOS). In our study, we expected that carrageenan 
injection cause elevation of nitric oxide production in the hind paw. Many reports 
have showed that injection with 1-3% of carrageenan has elevated the NO production 
in hind paws. Study by Mizokami et al., (2016) has shown that intraplantar injection 
of carrageenan on Male Swiss mice was able to induce nitric oxide (NO) production 
in the peritoneal cavity (Figure 4.12). Study by Boschi et al., (2008) showed that 
carrageenan increase the concentration of nitric oxide (NO) in the pleural cavity 
when compared to control group (Cg: 86.02 3.86 nmol, P ¼ 0.001) vs saline group 
(49.78 5.63 nmol)) (Figure 4.13). 
 
 
Figure 4.12 Nitrite production in peritoneal exudates was determined 3 hours after 






Figure 4.13 NO concentration in carrageenan and control group. Results are 
expressed as means SEM of eight animals. *P<0.05 (Boschi et al., 2008). 
 
Study by Salvemini,et al., 1996  has shown that intraplantar injection of carrageenan 
in male Sprague-Dawley rats increased in paw volume with an elevated production 
of NO2-/N03- in the paw exudates (Figure 4.14). This increase in N02-/NO3- was 
observed within 30 min (from 0.5 + 0.05 nmol/paw to 16.2 +4 nmol/paw, n = 6), 
remained constant for the subsequent 3 h and then increased further at 6 and 10 h 
following carrageenan administration (Figure 4.14 a and b). In addition, based on this 
study, L-NMMA (300 mg/kg, n = 5) inhibited the N02-/NO3- production in paw 
exudate at both 3 and 10 h after carrageenan administration (Figure 4.14 a and b). 
Therefore, we expect LNMMA will inhibit the production of NO 24 hours after 
injection with carrageenan. In addition, our treatment (50 mg/mL extracts + 
carrageenan) should inhibit/reduce the NO production at 24 hours post carrageenan 





Figure 4.14 Effects of carrageenan on NO2-/NO3- production at 3 (a) and 10 (b) h 
after carrageenan administration. The non-selective NOS inhibitors (LNMMA) 
inhibited NO2-/NO3- production at 3 and l0h (a and b), Each point is the 
mean+s.e.mean for n = 6. (Salvemini,et al., 1996). 
 
 
4.7.2 Quantification of Inflammatory Cells in H&E Stained Paw Tissue 
FBC analysis has revealed that carrageenan significantly increased monocytes count 
percentage when compared with DMSO + carrageenan treated rats. Carrageenan is 
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known to activate macrophages that will drive the local inflammatory reaction, and 
inflammatory cell infiltration. Therefore, histology analysis of paw tissue of 
carrageenan treated rats are expected to results in massive infiltrations of immune 
cells especially monocytes. We expect the DMSO + carrageenan group will results in 
more inflammatory cells infiltration compared to DMSO + saline group. Histological 
study by Buisseret et al., 2019 to assess immune cell infiltration of the paw was 
established at 6 and 24 h following carrageenan injection and revealed that 
carrageenan can induced a large infiltration of inflammatory cells in the paw, as seen 
in representative pictures (Figure 4.15 A and C). Consistently, a higher score was 
obtained in this group compared to the vehicle group for both time points. Study by 
Sadeghi et al., 2013 also suggests that carrageenan able to cause tissue changes, 




Figure 4.15 Mice were injected with 25 μL of carrageenan solution or saline vehicle into the plantar side of the right 
hindpaw. Mice were sacrificed at 6 h (A and B) or 24 h (C and D) after carrageenan injection. Representative pictures of 
hematoxylineosin stained sections, scale bar at 200 μm. (B and D) Histological scoring was performed at 6 (B) and 24 (D) 
hours after carrageenan administration. Values are mean ± s.e.m. (n = 8 per group). *P < 0.05, **P < 0.01, ***P < 0.001, 




Figure 4.16 Histopathological evaluation of rat paws 4 h after subplantar injection 
of carrageenan. (A) Appearance of epidermis and dermis in normal rats without any 
lesion. (B) Subplantar injection of carrageenan induced edema, and migration of 
leukocytes mainly neutrophils (Sadeghi et al., 2013). 
 
Study by Shin et al (2009) showed that carrageenan was able to increase the 
infiltration of immune cells including neutrophils, monocytes, and lymphocytes. 
Increase in neutrophils, monocytes, and lymphocytes are more prominent although 
eosinophils and basophils were slightly increasing following carrageenan injection 
(Table 4.2).  
Table 4.2 Immune cells infiltration after carrageenan injection (Shin et al 2009). 
Treatment Vehicle Carrageenan alone 
WBC 0.92 ± 0.29 9.44±3.31* 
Neutrophils 0.16 ± 0.06 0.94±0.31* 
Eosinophils 0.03 ± 0.02 0.06±0.04 
Basophils 0.05 ± 0.04 0.09±0.33 
Monocytes 0.07 ± 0.03 0.42±0.15* 
Lymphocytes 0.64 ± 0.19 7.82 ± 2.89* 






In this study, investigation of the effects of Fructus viticis methanolic crude 
extract on acute inflammatory pain evaluated by carrageenan induced paw oedema 
was done by assessing four parameters including paw thickness, pain threshold, 
systolic blood pressure, and full blood count analysis. In addition, antioxidant 
activity of Fructus viticis methanolic extract was investigated using DPPH radical 
scavenging assay. 
 
5.1 Fructus viticis effects on carrageenan-induced paw oedema model 
Carrageenan is a one of inflammatory agents that is commonly used for induction of 
acute inflammatory pain by intraplantar injection of animal model to develop paw 
oedema (Ou et al., 2019). Therefore, carrageenan- induced paw oedema model was 
used in this study as it is a well-defined, widely and frequently used working model 
of inflammation in the search for new anti-inflammatory drug (Kuedo et al., 2016). 
Furthermore, paw oedema is a convenient method for assessing inflammatory 
responses to antigenic challenges and irritants (Kuedo et al., 2016; Kim et al., 2020; 
Sarkhel, 2016).  
 
The thickness of paw oedema is one of the parameter taken for assessing the 
development of inflammation. Acute paw oedema are caused by the increased 
vascular permeability and plasma extravasation which caused accumulation of fluid, 
leukocytes and mediators at the site of inflammation (Helen et al., 2018). 
Inflammation induced by carrageenan is biphasic (Bao et al, 2018; Kim et al, 2018) 
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whereat the early phase (first 2 h after carrageenan injection) is attributed to the 
release of proinflammatory mediators, such as histamine and serotonin; the late 
phase (3–5 h after carrageenan injection) is mainly mediated by neutrophil 
infiltration into the inflammatory site and the production of large amounts of pro-
inflammatory mediators such as kinins, prostaglandin, nitric oxide, cyclooxygenase, 
cytokines such as IL-1β, IL-6, IL-10 and TNF-α, and neutrophil derived free radicals 
(Moon et al., 2018; Ismail et al., 2016; Kim et al, 2020).  
 
Previous studies have shown that intraplantar injection of carrageenan 
showed a noticeable difference in gross morphology such as increased redness, 
hotness, swelling, painful paw tissue oedema (Helen et al., 2018; Kim et al, 2020; 
Abd-Allah et al., 2018). Similarly, in our study it was demonstrated that injection of 
100 µL of 2% λ-carrageenan results in massive oedema (swelling) that characterized 
by the increase of paw thickness which significantly elevated within 30 minutes after 
carrageenan injection, reaching peak at 4 h to 8 h before starting to resolve at 24 
hours post-carrageenan injection. Paralleled with the study by Ialenti et al., (2017); 
Abd-Allah et al., (2018); Yuan et al., (2017) where paw oedema started to develop at 
0.5 h, where injection of 100 µL of 1% λ-carrageenan of carrageenan to the rat hind 
paw caused an oedema peaking between 3 and 4 hours. The peak time of eodema 
development is slightly different from our study because of the different carrageenan 
concentration used where in our study we used 2% (w/v) of λ-carrageenan instead of 
1% (w/v). 
 
Moreover, gross observation of rat hind paw treated with Fructus viticis extract 
showed less cardinal sign of inflammation including redness, heat, swelling and pain 
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compared to control (DMSO + Carrageenan). Our study has revealed that animal 
treated with Fructus viticis extract showed significant delay in the development of 
oedema at 4 h to 6 h post carrageenan injection when compared to control group 
(DMSO + Carrageenan). The ability of the extract to resolve the inflammation might 
be due to the bioactive compound in the crude extract that inhibit the known classical 
inflammatory pathway such as the Toll like receptor-4 (TLR4) mediated Nuclear 
factor kappa B (NF-κB) activation that control the regulation of proinflamamtory 
mediators.  Study by Liou and Huang., (2017) showed that casticin, a bioactive 
compound in Fructus viticis could suppress the inflammatory effect by blocking the 
NF-κB and MAPK pathways in TLR4 ligand LPS-induced RAW264.7 macrophage 
cells and decreases the levels of eotaxin and reduces eosinophil migration in IL-1β-
stimulated A549 human lung epithelial cells. Moreover, casticin may serve as a 
potential anti-inflammatory and anti-nociception agent when it significantly 
improved cell viability in chondrocytes exposed to IL-1β by inhibiting IL-1β-induced 
NO and PGE2 production, iNOS and COX-2 expression in human osteoarthritis 
chondrocytes and suppressed the levels of TNF-α and IL-6, as well as decreased 
production of MMP-3, MMP-13, ADAMTS-4 and ADAMTS-5 in IL-1β-stimulated 
chondrocytes. Study by Choi et al., (2010) on the effect of V. rotundifolia on the 
production of NO in IFN-gamma and LPS-stimulated mouse peritoneal macrophages 
showing that V. rotundifolia suppressed nitric oxide (NO) production, iNOS and 
COX-2 expression dose-dependently through suppression of NF-κB activation 





5.2 Systolic blood pressure measurement on carrageenan-induced 
inflammation model 
Carrageenan triggers the releasing of various cytokines that play critical role in the 
oedema formation, mechanical allodynia, neutrophil migration, and in pain 
hypersensitivity (Annamalai and Thangam, 2017). Therefore it was important to 
ensure that the animals did not experience intense systemic pain as the carrageenan 
are expected to only cause localized acute pain. It is known that pain can give rise to 
the blood pressure and hypertension as well as heart rate (Sacco et al., 2013). Over 
activity of the sympathetic nervous system (SNS) often leads to cardiovascular 
disease such as hypertension as well as increasing heart rate (Wang et al., 2017).  
Therefore blood pressure was used as indicator in pain development of animal 
models to ensure animals do not experience excruciating pain that can interrupt the 
animal’s welfare. Systolic blood pressure (SBP) of all animals that was measured by 
using tail-cuffed method has shown that there is no significant different blood 
pressure when compared statistically between groups.  Therefore, it can be concludes 
that the animals did not experienced systemic pain since the carrageenan only can 
induce acute inflammatory and localized pain at the site of injection.   
 
5.3 Fructus viticis as analgesic agent in acute pain 
The peripheral sensitization can be triggered by NF-κB-related pro-inflammatory 
mediators, including the cytokines TNF-α and IL-1β, as well as ROS, such as the 
superoxide anion radical (Kuedo et al., 2016). Carrageenan is found to induce 
inflammation and pain by direct binding to and activation of the TLR4 and NF-κB 
pathway thus induces oxidative stress (J.M. McKim Jr. et al., 2016; David et al., 
2020). Therefore, carrageenan model is frequently used to produce unilateral painful 
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inflammation (Harris-Bozer and Peng, 2016; Rock et al., 2018).  Carrageenan 
injection induced the expression of some inflammatory markers such as tumor 
necrosis factor (TNF)-α, interleukin (IL)-6, macrophage inflammatory protein 
(MIP)1α, COX2 and the macrophage activation marker CD11c thus causing 
peripheral hyperalgesia (Buisseret et al., 2019).  
 
 Study by Lauro et al., (2016) has shown that 1% intraplantar injection of 
carrageenan in rats hind paw produces a time dependent development of thermal 
hyperalgesia (pain sensation) which peaks within 2–3 h and lasts for another 6 h. In 
our study, rats injected with vehicle + carrageenan have significantly reduced 
mechanical nociception threshold from 1–6 h post carrageenan injection indicating 
increase in pain sensation. Interestingly, our study has revealed that rats that 
receiving 50mg/ml of Fructus viticis crude extract 30 minutes prior to carrageenan 
injection has showed a significant increase of mechanical nociception threshold 
(resolution of pain) when compared to rats injected with DMSO+Carrageenan at 1 
hour to 6 hours. Study has found that casticin, a bioactive compound of V. 
rotundifolia had significant anti-nociceptive using acetic acid writhing test and anti-
inflammatory effect on acute inflammation by xylene-induced ear edema (Ramezani 
et al., 2010). Moreover, methanolic extract of the fruits of V. rotundifolia showed the 
inhibitory effect on the NO production in RAW264.7 cells (Lee et al., 2013). In 
addition, diterpenoids that were isolated from Fructus viticis has significantly 
inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated 
RAW264.7 cells thus involves in anti-inflammatory activities (Yao et al., 2016). 
Instead of casticin, other compound present in V.rotundifolia such as aucubin which 
is another iridoids that can also be found in V. rotundifolia and this compound 
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possess anti-inflammatory activity when study revealed aucubin able to inhibit TNF-
α production in RAW 264.7 cells (Kyoung and Chang, 2004). 
 
5.4 Full Blood Count Analyses 
Earlier in the study we have shown that carrageenan has caused massive oedema 
probably due to the increase of immune cells infiltration. It has been reported that 
carrageenan can induce inflammatory activities by increasing macrophage 
phagocytosis, antibody production, lymphocyte proliferation, natural killer (NK) cell 
and NKT cell activity, pro-inflammatory cytokine secretion (Li et al., 2017). Our 
study has shown carrageenan has caused massive elevation of white blood cells when 
compared to control rats. However, Fructus viticis extract did not significantly 
reduced WBC and the WBC count was significantly higher when compared to 
control group.  Our study has shown that neutrophils count in blood shows no 
significant difference among groups at 24 hours post injection. However, result 
shows the percentage of neutrophils in blood of carrageenan-induced rats is the 
highest when compared to other groups. Caiazzo et al., (2016) revealed that 
neutrophils dominated the early phase (4 h) of the reaction and were replaced by 
monocytes at 72 h probably the reasons in our study there was no significant 
difference in neutrophils counts since the blood was taken 24 h after carrageenan 
injection.   
 
TNF-α, IL-1β, and IL-2 are pro-inflammatory cytokines produced by immune 
cells macrophages and monocytes in response to inflammation and cellular injury 
and causing pain (Zhang et al., 2020). Earlier study has shown that animals treated 
with carrageenan have developed intense hyperalgesia when they have lowered 
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mechanical nociception threshold, probably due to high infiltration of monocytes. 
Full Blood Count (FBC) analysis revealed that rats injected with carrageenan showed 
significant elevation of monocytes when compared to control rats. Interestingly, 
analysis on the monocytes count revealed that there was significant reduction of 
monocytes counts between the treatment, Fructus viticis extract and carrageenan 
group. Previous study has found that casticin isolated from Fructus viticis could 
suppress the inflammatory effect by blocking the NF-κB and MAPK pathways in 
LPS-induced RAW264.7 macrophage cells and decreases the levels of eotaxin and 
reduces eosinophil migration in IL-1β-stimulated A549 human lung epithelial cells 
(Liou et al., 2017). Furthermore, LNMMA + carrageenan treated rats also showed a 
significant reduction of monocytes count when compared to carrageenan group.  
 
As mentioned at the beginning, we have demonstrated that in FBC analysis 
carrageenan caused massive immune cells infiltration in the blood circulation. 
Therefore, histological analysis is required to further investigate the mechanism on 
how Fructus viticis extract exhibits its anti-inflammatory and analgesic effect 
particularly on the infiltration of immune cells in the paw tissues. However, due to 
COVID-19 pandemic and Malaysia Control Order (MCO), the fixed paw tissues are 
unable to be processed for histopathological analyses. Histopathological evaluation 
of the paw tissue of carrageenan-injected mice revealed epithelial hyperplasia, 
infiltration of inflammatory cell, and subepidermal oedema (Zhang et al., 2020). 
According to Jisha et al., (2019), carrageenan can cause manifestation of 
inflammatory cell infiltration, proliferated epithelium, proliferated collagen, 
epidermal oedema. Histopathological analysis of paw tissue has shown that paw 
tissue of the normal rats showed no signs of inflammation with normal keratin, sub 
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epidermal layer and sub cutaneous layer while rats treated with carrageenan shows 
massive influx of inflammatory cell infiltration, proliferated collagen, hyper keratotic 
skin, sub epidermal oedema, after 5 h after carrageenan injection (Helen et al., 2018; 
Jisha et al., 2019).  
 
5.2 Fructus viticis effects on carrageenan-induced paw oedema model 
Our study has revealed that Fructus viticis crude extract possesses high antioxidant 
activity when compared with BHT. Study has shown that methanolic extract of the 
twigs of V. rotundifolia possesses potent antioxidant activity when measuring the 
radical scavenging effect on DPPH (1,1-diphenyl- 2-picrylhydrazyl) when 2 
flavanoids,  orientin and a quinic acid derivative, 3,4-di-O-caffeoylquinic acid 
showed the significant antioxidative effects Lee et al., 2018, Yao et al., 2016, Kim, 
2009). Furthermore, ferruginol, an abietane-type diterpenoid isolated from V. 
rotundifolia showed higher antioxidant activity than 3-tert-butyl-4-hydroxyansiole 
(BHA) using the ferric thiocyanate method (Yao et al., 2016).  Study by Domingues 
et al., (2019) has shown that increases antioxidant presence in the intra-abdominal 
areas such as omental fat and ameliorates a prevalent metabolic syndrome 
complication such as fatty liver disease by promoting browning of white fat and 
more importantly reducing systemic inflammation. Bognar et al., (2013) revealed 
that high antioxidant compound augments LPS-induced Akt activation and MKP-1 
expression and attenuates mitochondrial destabilization, ROS production and 
activation of PARP as well as MAPKs resulting eventually in diminished activation 
of NFκB thus significantly contributes to the anti-inflammatory effects. The anti-
inflammatory action might be due to the overexpression of antioxidant enzymatic 
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systems leads to excess reducing equivalents that can deplete ROS, driving the cells 








As conclusion, methanolic extract of the Vitex rotundifolia fruits known as 
Fructus viticis exhibits anti-inflammatory effects by delaying the development of 
carrageenan-induced paw oedema at 4 h to 6 h which subsequently produces 
analgesic effect at certain period. Moreover, the ability of Fructus viticis extract to 
reduce the paw oedema as well as pain is suggested to be associated with the 
potential of the extract to reduce the infiltration of inflammatory cells which 
specifically the monocytes/macrophages into the hind paw. Interestingly, all 
treatment did not have significant effects on other type of immune cells such as 
lymphocytes, eosinophils and basophils which further suggest that the extract did not 
affect the innate immunity and allergic reaction. Moreover, anti-inflammatory and 
analgesic effects of Fructus viticis extract might be the direct consequences of 
antioxidant activity of Fructus viticis.  Overall, the fruit of V.rotundifolia has a 
potential to be developed into a novel antiinflammatory and analgesic drugs and 
other pharmacological products in future. 
 
6.1 Limitations 
Some of the many limitations that we have encountered throughout the study 
were assessing the pain behaviour of the rats using Randall-Selitto test. A few rats 
exhibited uncomfortable behaviour and hypersensitive even with prior sufficient 
acclimatization and handling. This occurrence indirectly delayed the time as we 
required the rats to be as calm as possible to yield a consistent and reproducible data. 
Moreover, paw oedema was measured by using a Digital Vernier Caliper which 
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measures the paw thickness between the plantar and dorsal of the paw. This 
technique only measures certain area of the paw which can be bias among different 
experimenter. Another method used to determine the types of inflammatory cells 
infiltrated was less precise as it measures inflammatory cells in the systemic 
circulation using full blood count analyses, and not quantified from the paw tissues 
directly. Moreover, the blood was taken only after 24 h post carrageenan injection. 
This data may not precisely represent the present of specific immune cells in blood, 
especially at the early phase of carrageenan induction. Furthermore, some part of our 
study such as histopathological analyses and determination of inflammatory mediator 
nitric oxide (NO) cannot be conducted because of Covid-19 pandemic and Malaysia 
Control Order (MCO).  
 
6.2 Recommendation 
The development of paw oedema and the effects of treatment on the paw can 
be measured accurately by using other alternative apparatus such as plesthymometer 
that measure the total volume of the whole paw. Von Frey Filament and 
Incapacitance machine are another alternative in assessing pain behaviour as this 
method does not require the experimenter to hold the animals which can reduce the 
stress of the animal. This will yield to a consistent and reproducible data as the 
animals are calmer. In this study, it is vital to determine the specific inflammatory 
cells in the paw tissue; therefore the most suitable method is by applying 
immunohistochemistry onto the paw tissue. Moreover, the experimental time can be 
reduce from 24 h to 12 h as our study has shown that carrageenan induce 
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𝑥𝑥 = 0.25 𝑚𝑚𝑚𝑚 
From here, the volume of dose injected to the rats is determined based on the rat’s 
body weight 
